# Chapter 88: Male Hypoactive Sexual Desire Disorder

# The Biological and Neurological Basis of Male Hypoactive Sexual Desire Disorder

## Introduction

Male Hypoactive Sexual Desire Disorder (MHSDD) is a prevalent and often distressing condition characterized by a persistent or recurrent deficiency or absence of sexual fantasies and desire for sexual activity (Snyder et al., 2016; Corona et al., 2006). For a formal diagnosis, these symptoms must cause marked personal distress or interpersonal difficulty and cannot be better accounted for by another primary psychiatric disorder or the direct physiological effects of a substance or a general medical condition (Snyder et al., 2016; Clayton et al., 2010; Montgomery, 2008). While often underreported and underdiagnosed due to patient embarrassment or a clinician's reluctance to inquire about sexual health (Payne & Sadovsky, 2007; King, 2007), MHSDD represents a significant challenge to an individual's quality of life, self-esteem, and intimate relationships (Nicol & Chung, 2023; Sharma, 2019).

The etiology of MHSDD is decidedly multifactorial, representing a complex interplay of biological, psychological, interpersonal, and sociocultural factors (Wierman & Cassel, 1998; Kockott, 1990; Halvorsen & Metz, 1992). This chapter will focus specifically on the biological and neurological underpinnings of the disorder, synthesizing the available evidence to construct a comprehensive understanding of its physiological basis. While psychological factors such as performance anxiety, relationship conflict, and prior sexual trauma are critical components of a complete clinical picture (Weiss et al., 1997; Hartmann, 1998), the biological dimension provides the fundamental framework upon which these psychological and social factors operate.

The biological investigation into low sexual desire encompasses a wide range of systems, including the endocrine, vascular, and neurological domains (Abdo, 2017; Sengupta & Tasneem, 2023). Hormonal regulation, particularly the roles of testosterone and prolactin, has been identified as a cornerstone in the modulation of male libido (Corona et al., 2006; Janmohamed & Bouloux, 2016). Concurrently, the central nervous system's intricate network of neurotransmitters, including serotonin, dopamine, and norepinephrine, plays a crucial modulatory role, a fact starkly highlighted by the profound sexual side effects of many psychotropic medications (Sonavane et al., 2023; Montejo et al., 2018; Hindmarch, 1998).

Furthermore, the integrity of the neurological system is paramount for normal sexual function, and various neurological disorders, from epilepsy to stroke, are frequently associated with diminished desire (Morrell, 1991; Calabrò et al., 2011). The influence of aging, chronic medical illnesses (e.g., chronic kidney disease, diabetes, cardiovascular disease), and chronic pain also contribute significantly to the organic basis of MHSDD, often creating a complex web of interacting pathologies (Quadri & Fonzo, 1993; Unknown, 2008; Bilous & Donnelly, 2010; Wagner & Sáenz de Tejada, 1998). A significant portion of MHSDD cases can be attributed to iatrogenic causes, particularly the use of medications for treating comorbid conditions such as depression and hypertension (Razdan et al., 2017; Conaglen & Conaglen, 2013).

This chapter aims to systematically explore these biological and neurological mechanisms. It will delve into the roles of neurotransmitter and neuroendocrine systems, examine the impact of comorbid medical and psychiatric conditions from a biological perspective, and discuss the neuropharmacological basis of both the disorder and its common iatrogenic forms. By synthesizing the evidence from the provided research, this chapter will construct a detailed, evidence-based overview of the biological architecture of male sexual desire and its dysfunction, providing a foundation for a more nuanced and integrated approach to the diagnosis and management of MHSDD.

## Neurobiological Systems

The biological regulation of male sexual desire is not governed by a single system but rather by a complex and integrated network of neuroendocrine and neurochemical pathways. Disruptions at any point in this network can lead to the clinical manifestation of MHSDD. The primary systems implicated in the literature include the endocrine system, particularly the hypothalamic-pituitary-gonadal (HPG) axis, and central neurotransmitter systems, with serotonin and dopamine being of principal importance.

### Endocrine and Hormonal Systems

The endocrine system is a fundamental regulator of sexual function, with hormones directly and indirectly modulating all phases of the sexual response, including desire (Balercia et al., 2007). The most critical hormonal factors in the control of male sexual desire are testosterone and prolactin (Corona et al., 2006).

**Testosterone and Hypogonadism:** Hypogonadism, a clinical syndrome resulting from sub-physiological testosterone levels, is recognized as a major organic cause of male sexual dysfunction, including low desire (Rochira et al., 2022; Janmohamed & Bouloux, 2016). Testosterone is a key molecule that can influence not only physical health but also mental and psychological well-being (Okada et al., 2016). Its role extends beyond sexual behavior to affect mood, concentration, and a general sense of vigor (Mooradian & Korenman, 2006). While the relationship is not always linear, low testosterone levels are frequently associated with decreased libido (Fujita et al., 1997; Quadri & Fonzo, 1993). Studies have shown that testosterone levels must fall significantly below the normal range before a noticeable impairment in sexual interest occurs (Levy et al., 2000). The age-related decline in testosterone is a well-documented phenomenon, contributing to the increased prevalence of sexual dysfunction in older men (Mooradian & Korenman, 2006; Quadri & Fonzo, 1993; Delev et al., 2009). This condition, sometimes termed late-onset hypogonadism (LOH) or andropause, is associated with a constellation of symptoms including loss of libido, erectile dysfunction, fatigue, and mood changes (Okada et al., 2016; Staerman & Léon, 2012; Cui, 2005). The diagnosis of hypogonadism requires confirmation of low testosterone levels on at least two separate occasions (Bucher & Christ, 2014) and is a crucial consideration in the evaluation of any man presenting with low sexual desire (Miller, 2000; Greiner & Weigel, 1996). The importance of testosterone is further underscored by the observation that testosterone replacement therapy can improve erections and desire in men with documented hypogonadism (Rochira et al., 2022; Mooradian & Korenman, 2006).

**Hyperprolactinemia:** Prolactin is another hormone with a profound impact on male sexual desire. Hyperprolactinemia, or elevated prolactin levels, is a significant cause of diminished libido (Corona et al., 2006). This effect can be mediated centrally, through a reduction in sexual interest, and may be independent of circulating testosterone levels (Levy et al., 2000). A major clinical cause of hyperprolactinemia is the use of certain psychotropic medications, particularly antipsychotics that are potent dopamine D2 receptor antagonists (Maguire, 2002; Montejo et al., 2018; La Torre et al., 2013). This drug-induced elevation of prolactin often leads to sexual dysfunction, including decreased libido, which can be a major cause of non-adherence to treatment (Maguire, 2002; Montejo et al., 2015). Research suggests that severe hyperprolactinemia may play a greater role than hypogonadism in the pathogenesis of MHSDD (Corona et al., 2006). Clinically, this highlights the importance of measuring prolactin levels in patients with low desire, especially those taking antipsychotic medications (Maguire, 2002).

**Other Endocrine Factors:** Beyond testosterone and prolactin, other endocrine systems are implicated in sexual function. Thyroid disorders, including both hyper- and hypothyroidism, can affect sexual desire (Balercia et al., 2007; Broul et al., 2024). The hypothalamic-pituitary-adrenal (HPA) axis, which governs the stress response, is also critically involved. Chronic stress can lead to dysregulation of the HPA axis, with alterations in cortisol secretion that may contribute to mood disorders and, consequently, reduced libido (Hellhammer & Wade, 1993; Schneiderman et al., 2004). Indeed, some studies have noted associations between delusional jealousy, a state of high psychological stress, and altered testosterone and cortisol levels alongside hypoactive sexual desire (Pinho et al., 2024). Diabetes mellitus is another endocrine disorder strongly associated with sexual dysfunction, including erectile dysfunction and, by extension, potential impacts on desire, often through its effects on vascular and neurological systems (Bilous & Donnelly, 2010; Nusbaum, 2002).

### Neurotransmitter Systems and Neuropharmacology

The central nervous system orchestrates sexual desire through a delicate balance of excitatory and inhibitory neurotransmitters. The clinical evidence for the roles of these systems comes largely from observing the sexual side effects of psychotropic drugs that target them (Sonavane et al., 2023; Montejo et al., 2018; Higgins, 2010).

**Serotonin (5-HT):** The serotonergic system is arguably the most implicated neurotransmitter system in drug-induced sexual dysfunction. Antidepressants with predominantly serotonergic activity, particularly Selective Serotonin Reuptake Inhibitors (SSRIs), are consistently associated with a high incidence of sexual side effects, including decreased libido (Montejo et al., 2018; Higgins, 2010; Baldwin & Foong, 2013). The mechanism is thought to involve the stimulation of specific serotonin receptors, such as the 5-HT2 receptor, which has an inhibitory effect on sexual function (Hirschfeld, 1999; Rosen et al., 1999). This inhibitory action can disrupt the cognitive structures essential for maintaining normal libido, leading to anhedonia that extends to sexual activities (Hindmarch, 1998). The fact that SSRIs are used off-label to treat premature ejaculation by delaying orgasm further highlights serotonin's inhibitory role in the sexual response cycle (Giuliano & Hellstrom, 2008; McMahon, 2014). The high rates of SSRI-induced sexual dysfunction are a major cause of treatment non-adherence in patients with depression (Rosen et al., 1999; Zajecka, 2001).

**Dopamine:** Dopamine is fundamentally involved in motivation, reward, and pleasure, making it a key excitatory neurotransmitter for sexual desire (Blum et al., 2015; Montejo et al., 2020). The mesolimbic dopamine pathway, often referred to as the brain's reward circuit, is activated by natural rewards such as food and sex (Blum et al., 2015; Vanderschuren, 2008). Antipsychotic medications, which primarily function by blocking D2 dopamine receptors, frequently cause sexual dysfunction, including decreased libido (La Torre et al., 2013; Mitchell & Popkin, 1982; Montejo et al., 2015). This effect is thought to be due to both direct blockade of dopamine's pro-sexual effects and the indirect effect of dopamine blockade in the tuberoinfundibular pathway, which leads to hyperprolactinemia (Maguire, 2002; La Torre et al., 2013). Conversely, some drugs that enhance dopamine activity, such as bupropion, have a lower propensity to cause sexual side effects and may even be used as an augmentation strategy to counteract SSRI-induced dysfunction (Zajecka, 2001; Hirschfeld, 1999). This provides strong pharmacological evidence for dopamine's central role in facilitating sexual desire.

**Norepinephrine:** The noradrenergic system is also involved in modulating sexual function. Some antidepressants that affect norepinephrine, such as tricyclic antidepressants, have been associated with sexual side effects (Hirschfeld, 1999; Aversa et al., 1998). However, the effects are complex; for example, some antidepressants that target norepinephrine do not cause sexual dysfunction and may be preferred alternatives to SSRIs (Montejo et al., 2015). The role of the sympathetic nervous system, which utilizes norepinephrine, is crucial for processes like ejaculation and detumescence (Levy et al., 2000), but its direct role in the subjective experience of desire is less clearly defined in the provided literature.

**Other Neurochemical Factors:** Other systems are also involved. γ-Aminobutyric acid (GABA), the brain's primary inhibitory neurotransmitter, is implicated in the pathophysiology of anxiety and mood disorders, which are often comorbid with low desire (Zutshi et al., 2007). Anticholinergic effects of certain drugs, such as older tricyclic antidepressants and some antipsychotics, can also contribute to sexual dysfunction, though these are often more related to arousal (e.g., erectile problems) than desire itself (Rosen et al., 1999; Mitchell & Popkin, 1982). Ultimately, the sexual response cycle is modulated by a complex interaction between these neurotransmitter systems, and an imbalance, whether from a primary psychiatric disorder or iatrogenic effects, can lead to a clinically significant loss of desire (Sonavane et al., 2023; Sonavane et al., 2023).

## Genetic and Molecular Basis

The exploration of the genetic and molecular underpinnings of Male Hypoactive Sexual Desire Disorder is an emerging field, and the provided literature offers limited specific insights into this area. While a definitive genetic architecture for MHSDD has not been delineated, several lines of evidence suggest that genetic factors likely play a predisposing role, often through their influence on comorbid conditions and fundamental neurobiological systems.

### Heritability and Genetic Predisposition

The concept that genetic factors contribute to the risk of developing MHSDD is supported indirectly by research into its common comorbidities. For instance, mood disorders and substance use disorders, both of which are strongly associated with sexual dysfunction including low libido, have well-established genetic components (Coppen & Swade, 1988; Cadoret & Winokur, 1972). Family studies of individuals with alcohol dependence show a greater prevalence of the disorder in relatives, suggesting a genetic trait (Cadoret & Winokur, 1972). Similarly, major depression is known to run in families (Rice et al., 2002; Roy, 1996). Given the high comorbidity between depression and low sexual desire (Fabre et al., 2013; Bartlik et al., 2001), it is plausible that a shared genetic vulnerability may underlie both conditions. Research into the origins of late-life depression explicitly identifies genetics and heredity as key biological factors (Blazer & Hybels, 2005).

Furthermore, some research points toward the need for increased investigation into the genetic variables related to sexual life to better understand the mechanisms involved in sexual function and dysfunction (Montejo, 2020). The multifactorial etiology of MHSDD, which includes biological, psychological, and social components (Wierman & Cassel, 1998), is consistent with complex genetic disorders where multiple genes interact with environmental factors to produce a clinical phenotype. For example, individual differences in endocrine responsiveness to stress, which affects the HPA axis and can impact libido, are thought to have a large genetic component (Hellhammer & Wade, 1993). Similarly, genetic factors are implicated in the development of personality traits, such as neuroticism, which predispose individuals to both depression and anxiety, and by extension, to sexual desire problems (Segraves, 2008; Kirilly et al., 2013).

### Candidate Genes and Molecular Pathways

The provided literature does not identify specific candidate genes for MHSDD. However, based on the established roles of various neurobiological systems, it is possible to hypothesize about the types of molecular pathways that are likely involved.

**Neurotransmitter Systems:** Genes that regulate the synthesis, transport, and reception of key neurotransmitters like dopamine and serotonin are strong candidates for involvement in sexual desire. For instance, polymorphisms in genes related to the dopamine system could influence an individual's reward sensitivity and motivation, which are central to sexual desire (Blum et al., 2015). Similarly, genetic variations in the serotonin system could affect the inhibitory tone on sexual function, potentially predisposing some individuals to lower baseline desire or a greater susceptibility to the libido-reducing effects of SSRIs (Rosen et al., 1999).

**Endocrine Systems:** The molecular pathways governing the hypothalamic-pituitary-gonadal (HPG) axis are also of critical importance. Genetic factors are known to play a role in conditions like congenital hypogonadotropic hypogonadism (Dwyer et al., 2019) and Klinefelter's syndrome (47,XXY), a common cause of male hypogonadism (Zitzmann & Rohayem, 2020; Gooren & de Ronde, 2006). These conditions, which directly impact testosterone production, provide a clear model for how genetic abnormalities can lead to profound deficits in sexual desire (Janmohamed & Bouloux, 2016). More subtle genetic variations affecting androgen receptor sensitivity or the regulation of testosterone production could plausibly contribute to the spectrum of sexual desire seen in the general population and the vulnerability to developing MHSDD.

**Stress Response Systems:** Early life stress has been shown to have enduring effects on gene expression through epigenetic mechanisms, leading to impaired HPA axis functioning (Wuergezhen, 2019). These long-term alterations in stress system regulation can increase vulnerability to psychiatric disorders like depression and anxiety later in life (Meyer & Hamel, 2014), which are, in turn, major risk factors for low sexual desire. Therefore, the molecular mechanisms that mediate the long-term effects of stress on the brain represent another important area for future investigation into the etiology of MHSDD.

In summary, while direct genetic evidence for MHSDD is scarce in the provided sources, the strong heritable components of its comorbid psychiatric disorders and the known genetic basis of the underlying endocrine and neurotransmitter systems strongly suggest a role for genetic and molecular factors. Future research is needed to move from these indirect associations to the identification of specific genes and pathways that confer vulnerability to low sexual desire in men (Montejo, 2020).

## Brain Structure and Function

While the subjective experience of sexual desire is a psychological phenomenon, it is fundamentally rooted in the structure and function of the brain. The available literature, though lacking direct neuroimaging studies on MHSDD, provides important clues about the key brain regions and neural circuits involved in the regulation of sexual behavior. These insights are largely derived from studies of brain injury, neurological diseases, and the mechanisms of action of psychotropic drugs.

### Implicated Brain Regions and Neural Circuits

The regulation of sexual desire is not localized to a single brain area but involves a distributed network of cortical and subcortical structures. This network integrates hormonal signals, sensory information, emotional states, and cognitive appraisals to generate the motivational drive for sexual activity.

**Hypothalamus and Pituitary Gland:** The hypothalamus is a critical hub in this network, playing a central role in regulating the endocrine system via the pituitary gland. It is the primary site for the regulation of the hypothalamic-pituitary-gonadal (HPG) axis, which controls the production of testosterone—a key hormone for male libido (Janmohamed & Bouloux, 2016; Rochira et al., 2022). Conditions affecting the hypothalamus or pituitary, such as tumors or functional suppression due to stress or weight loss, can lead to hypogonadotropic hypogonadism and a subsequent loss of sexual desire (Silveira & Latrônico, 2013). The hypothalamus also integrates signals related to satiety, stress, and circadian rhythms, all of which can influence sexual motivation (Latta & Van Cauter, 2003).

**Limbic System:** The limbic system, which includes structures like the amygdala and hippocampus, is central to emotional processing and memory, both of which are integral to sexual desire. The amygdala is involved in processing emotionally salient stimuli and is implicated in the brain's response to stress and anxiety, which can potently inhibit sexual desire (Schneiderman et al., 2004). Evidence from brain injury studies suggests that damage to limbic system structures can lead to profound alterations in sexual preference and behavior (Miller et al., 1986). Furthermore, the hippocampus, crucial for memory, is involved in associating cues with sexual reward, a process that can be disrupted in conditions like depression and schizophrenia (Tamminga et al., 1998; Mucci et al., 2021). The profound emotional changes seen in mood disorders, which are strongly linked to limbic dysfunction, frequently manifest as anhedonia and loss of libido (Manohar et al., 2017; Bains et al., 2021).

**Frontal and Temporal Lobes:** Higher-order cognitive and executive functions, mediated by the frontal lobes, are essential for regulating and directing sexual behavior. The prefrontal cortex is involved in judgment, impulse control, and social cognition (Miller et al., 1986; Herpertz & Saß, 2000). Dysfunction in this region, as seen in frontotemporal dementia or following traumatic brain injury, can lead to disinhibited or inappropriate sexual behaviors (Ward & Manchip, 2012; Miller et al., 1986), highlighting its role in the top-down control of sexual urges. Conversely, apathy and loss of motivation, core features of some frontal lobe syndromes, can manifest as a profound lack of sexual desire (van den Berg et al., 2015). Temporal lobe abnormalities, particularly in the context of epilepsy, have also been associated with hypersexuality and paraphilias, suggesting their involvement in the generation and modulation of sexual drive (Chughtai et al., 2009; Morrell, 1991).

**Reward Circuitry:** The motivation to engage in sexual activity is driven by the brain's reward system, a circuit that is also central to addiction (Calderón, 2021; Blum et al., 2015). The mesolimbic dopamine pathway, originating in the ventral tegmental area and projecting to the nucleus accumbens and prefrontal cortex, is the core of this system (Vanderschuren, 2008). This pathway mediates the reinforcing effects of natural rewards like sex and is crucial for "wanting" or desire (Blum et al., 2015). A hypoactive state in this dopaminergic circuit, whether due to a primary psychiatric disorder like depression or the effects of dopamine-blocking antipsychotic drugs, is a plausible neurobiological substrate for MHSDD (Montejo et al., 2020; La Torre et al., 2013). The anhedonia characteristic of depression, which includes a loss of sexual pleasure and desire, is thought to be linked to dysfunction in this very circuit (Manohar et al., 2017; Hindmarch, 1998).

### Neuroimaging Findings (Structural and Functional)

It is critical to note that none of the provided research papers contain direct structural or functional neuroimaging findings (such as MRI, fMRI, or PET scans) specifically investigating the brains of men with a primary diagnosis of Male Hypoactive Sexual Desire Disorder. The understanding of the neural correlates of MHSDD is therefore inferred from studies of related conditions.

For example, neuroimaging studies in depression have revealed structural and functional abnormalities in the prefrontal cortex, hippocampus, and amygdala—regions integral to mood regulation and, by extension, sexual desire (Blumenthal & Lett, 2005; Sahakian & Morein‐Zamir, 2011). Similarly, studies in schizophrenia have noted structural changes, including ventricular enlargement and reduced volume in frontal, temporal, and limbic regions, which may contribute to the negative symptoms of the illness, including avolition and anhedonia (Harvey, 2001; Tamminga et al., 1998). Functional neuroimaging has also implicated hypofrontality (reduced frontal lobe activity) in the negative and cognitive symptoms of schizophrenia (Harvey, 2001; Tamminga et al., 1998). While these findings are not specific to MHSDD, they support the hypothesis that dysfunction in these fronto-limbic circuits, which are heavily modulated by dopamine and serotonin, underlies the loss of motivation and desire seen in both primary psychiatric disorders and MHSDD. Future research employing neuroimaging techniques is urgently needed to directly investigate the neural signatures of low sexual desire in men, which would help to clarify the pathophysiology and identify potential targets for novel treatments (Montejo, 2020).

## Developmental Neurobiology

The emergence and expression of Male Hypoactive Sexual Desire Disorder across the lifespan are influenced by a confluence of developmental, biological, and psychosocial factors. While MHSDD can present at any point in adulthood, its prevalence, clinical features, and underlying mechanisms are significantly shaped by the processes of aging and the developmental timing of comorbid medical and psychiatric conditions.

### Aging and Senescence

Aging is one of the most consistently identified risk factors for sexual dysfunction in men, including decreased libido (Segraves, 2008; Nusbaum, 2002). The decline in sexual desire with age is a multifactorial process. Physiologically, normal aging is associated with a gradual decline in circulating testosterone levels, a key hormonal driver of male libido (Mooradian & Korenman, 2006; Quadri & Fonzo, 1993; Delev et al., 2009). This age-related decline in androgen production contributes to the clinical picture of "andropause" or late-onset hypogonadism, which frequently includes diminished sexual interest as a cardinal feature (Staerman & Léon, 2012; Cui, 2005).

Beyond hormonal changes, the aging process is accompanied by an increased prevalence of chronic medical conditions that are themselves potent risk factors for MHSDD. Cardiovascular disease, hypertension, and diabetes mellitus become more common with age and can impair sexual function through vascular and neurological mechanisms (Wierman & Cassel, 1998; Wagner & Sáenz de Tejada, 1998; Bilous & Donnelly, 2010). Similarly, neurological disorders such as stroke and Parkinson's disease, which are more prevalent in older populations, are often associated with a decline in libido (Calabrò et al., 2011; Bronner & Vodušek, 2011). Age-related changes in the autonomic nervous system may also affect sexual response (Thomsen & Olesen, 2013).

Psychosocially, older age is often accompanied by significant life stressors, such as retirement, loss of a spouse, social isolation, and concerns about physical health, all of which can precipitate or exacerbate depressive and anxiety symptoms (Sekhon et al., 2019; Blazer & Hybels, 2005; Harris, 1983). Given the strong link between depression and low sexual desire, these age-related psychosocial challenges are critical contributors to MHSDD in the elderly (Manohar et al., 2017; Phillips & Slaughter, 2000). Furthermore, the physical limitations and functional decline that can accompany old age may create both physical and psychological barriers to sexual activity, further diminishing desire (Colón‐Emeric et al., 2013; Topinková, 2008).

### Adolescence and Early Adulthood

While MHSDD is typically diagnosed in adulthood, its developmental antecedents can often be traced back to adolescence and early adulthood, a critical period for psychosexual development and the onset of many major psychiatric disorders (Snyder et al., 2016). Adolescence is a time of significant hormonal and neurological maturation, and disruptions during this period can have lasting consequences (Wa, 1985). The onset of disorders such as schizophrenia, bipolar disorder, and major depression frequently occurs during late adolescence or early adulthood (Isohanni et al., 2020; di Giacomo et al., 2023; Hechtman, 1991). These conditions are often characterized by profound disturbances in motivation, pleasure, and social functioning, which can manifest as a primary lack of sexual interest (Tamminga et al., 1998; Manohar et al., 2017). For example, the negative symptoms of schizophrenia, such as avolition and anhedonia, are core features of the illness that can emerge early and persist, leading to a profound and enduring lack of libido (Golubtsova et al., 1988; Tamminga et al., 1998).

Furthermore, early life stress and childhood trauma, including physical or sexual abuse, are significant risk factors for the development of a wide range of adult psychiatric problems, including depression, anxiety, personality disorders, and substance use disorders (Meyer & Hamel, 2014; Wuergezhen, 2019; Butler, 1993). These disorders are, in turn, strongly associated with sexual dysfunction in adulthood (Butler, 1993). Early trauma can lead to long-term alterations in stress-response systems (HPA axis) and brain development, creating a neurobiological vulnerability that may manifest later in life as both mood instability and impaired sexual function (Meyer & Hamel, 2014; Rothenberger & Hüther, 1997). Therefore, a developmental perspective is crucial for understanding the origins of MHSDD, as experiences during critical periods of childhood and adolescence can establish the biological and psychological groundwork for the disorder's emergence in adulthood.

In summary, the neurobiology of MHSDD is not static but evolves across the lifespan. The hormonal and neurological changes of aging create a direct biological vulnerability to decreased desire in later life, which is compounded by the accumulation of comorbid diseases and psychosocial stressors. Concurrently, the foundations for MHSDD are often laid much earlier, during the critical developmental windows of adolescence and early adulthood, when the onset of major mental illness or the long-term consequences of early life stress can profoundly disrupt the maturation of the neural and endocrine systems that govern healthy sexual desire.

## Treatment Mechanisms

The management of Male Hypoactive Sexual Desire Disorder is guided by its multifactorial etiology, with treatment strategies targeting the underlying biological and neurological dysfunctions. An effective approach requires a thorough assessment to identify causative factors, which may include hormonal deficiencies, iatrogenic effects of medication, or the neurobiological sequelae of comorbid psychiatric disorders (Rochira et al., 2022; Nicol & Chung, 2023).

### Hormonal Interventions

Given the pivotal role of testosterone in male libido, addressing hypogonadism is a primary therapeutic strategy. Testosterone replacement therapy (TRT) is the cornerstone of treatment for men with well-documented testosterone deficiency (Rochira et al., 2022; Mooradian & Korenman, 2006). The biological mechanism of TRT involves restoring physiological androgen levels, which in turn acts on central and peripheral androgen receptors to enhance sexual desire, motivation, and erectile function (Janmohamed & Bouloux, 2016; Gooren & de Ronde, 2006). Restoring testosterone can improve not only libido but also related symptoms such as fatigue, low energy, and depressed mood, which can secondarily contribute to better sexual function (Orengo et al., 2004; Mooradian & Korenman, 2006). The efficacy of TRT is most pronounced in individuals with clear hypogonadism (Levy et al., 2000), and its use should be guided by confirmed low testosterone levels and clinical symptoms (Bucher & Christ, 2014; Staerman & Léon, 2012).

Another key hormonal target is prolactin. In cases of hyperprolactinemia, particularly when induced by antipsychotic medications, management may involve switching to a "prolactin-sparing" antipsychotic (e.g., aripiprazole, quetiapine) that has a lower affinity for D2 receptor blockade in the tuberoinfundibular pathway (Montejo et al., 2018; Maguire, 2002). In some cases, dopamine agonists like bromocriptine can be used to lower prolactin levels and restore sexual desire (Levy et al., 2000). The mechanism involves mimicking dopamine's natural inhibitory effect on pituitary prolactin secretion, thereby reversing the hormonal imbalance that suppresses libido (Balercia et al., 2007).

### Management of Iatrogenic Sexual Dysfunction

A significant number of MHSDD cases are iatrogenic, caused by medications prescribed for other conditions, most notably depression and psychosis (Razdan et al., 2017; Conaglen & Conaglen, 2013). Managing these cases involves a careful balancing of the risks and benefits of altering a patient's primary psychiatric treatment.

For antidepressant-induced sexual dysfunction, particularly from SSRIs, several strategies target the underlying neuropharmacology. One approach is dose reduction, as the sexual side effects of SSRIs are often dose-dependent (Rosen et al., 1999; Zajecka, 2001). However, this risks the re-emergence of depressive symptoms. A more common and often more effective strategy is to switch to an antidepressant with a different mechanism of action and a lower propensity for sexual side effects (Hirschfeld, 1999; Zajecka, 2001). Antidepressants with less potent serotonergic effects or with additional dopaminergic or noradrenergic activity, such as bupropion, mirtazapine, or nefazodone, are often preferred alternatives (Hirschfeld, 1999; Michael & O’Keane, 2000). Another approach is augmentation, where a second medication is added to counteract the sexual side effects of the primary antidepressant. Agents that enhance dopamine function (e.g., bupropion) or block 5-HT2 receptors may be effective (Hirschfeld, 1999; Zajecka, 2001).

For antipsychotic-induced sexual dysfunction, management often focuses on mitigating hyperprolactinemia. This can be achieved by switching from a high-prolactin agent (e.g., risperidone, typical antipsychotics) to one with a lower risk, such as aripiprazole or olanzapine (Montejo et al., 2018; Maguire, 2002). This switch reduces D2 receptor blockade in the pituitary, allowing dopamine's natural inhibition of prolactin to resume (La Torre et al., 2013).

### Pharmacological Approaches for Comorbidities

When low desire is secondary to a primary psychiatric disorder like major depression or an anxiety disorder, the primary treatment goal is the effective management of that disorder (Manohar et al., 2017; Bartlik et al., 2001). Successful treatment of depression often leads to a spontaneous resolution of associated sexual dysfunction as symptoms like anhedonia, fatigue, and low motivation improve (Michael & O’Keane, 2000; Phillips & Slaughter, 2000). However, the challenge lies in selecting a treatment that resolves the mood disorder without inducing its own sexual side effects (Hirschfeld, 1999). This highlights the importance of choosing antidepressants with favorable sexual side-effect profiles as a first-line option in sexually active patients (Zajecka, 2001).

In men with erectile dysfunction (ED) and comorbid low desire, treatment with phosphodiesterase type 5 (PDE5) inhibitors like sildenafil can play a role (Greiner & Weigel, 1996). While these agents do not directly increase libido, they improve erectile function by enhancing nitric oxide-mediated vasodilation in the corpus cavernosum (Levy et al., 2000). The restoration of reliable erectile function can break the cycle of performance anxiety and fear of failure, leading to increased self-esteem and sexual confidence (Seidman, 2002; Wang, 2011). This psychological improvement can, in turn, lead to a secondary increase in sexual desire.

In conclusion, the biological treatment of MHSDD is mechanism-based and highly individualized. It requires a comprehensive evaluation to identify underlying endocrine abnormalities, iatrogenic factors, and comorbid psychiatric conditions. Interventions range from direct hormonal replacement to strategic modification of psychotropic medication regimens and treatment of related dysfunctions like ED, all aimed at restoring the neurobiological balance necessary for healthy sexual desire.

## Future Directions

The current understanding of the biological and neurological basis of Male Hypoactive Sexual Desire Disorder, as synthesized from the available literature, is characterized by broad principles rather than specific, detailed mechanisms. While significant progress has been made in identifying key hormonal and neurotransmitter systems, as well as the impact of comorbid conditions, numerous questions remain unanswered. The field is poised for significant advancement, contingent on addressing several critical gaps in the existing research.

A primary future direction must be the direct investigation of the neurobiology of MHSDD itself, rather than relying on inferences from comorbid disorders or drug side effects. There is a pressing need for neuroimaging studies—both structural and functional—to identify the specific brain regions and neural circuits that are dysfunctional in men with primary low sexual desire (Montejo, 2020). Such studies could clarify whether MHSDD is associated with structural changes in areas like the hypothalamus or prefrontal cortex, or with functional alterations in the connectivity of fronto-limbic and reward pathways. This research would help to move the field beyond general hypotheses about the involvement of these circuits and toward a more precise neuroanatomical and functional map of the disorder.

Another crucial area for future research is genetics and molecular biology. While a genetic predisposition is suspected, no specific genes for MHSDD have been identified (Montejo, 2020). Genome-wide association studies (GWAS) could help to uncover genetic variants that confer vulnerability, perhaps by influencing androgen receptor sensitivity, dopamine pathway function, or serotonin metabolism. Furthermore, exploring the role of epigenetics, particularly how early life stress and trauma might induce lasting changes in gene expression related to the HPA and HPG axes, could provide profound insights into the developmental pathways of the disorder (Wuergezhen, 2019; Meyer & Hamel, 2014). This would help bridge the gap between psychosocial risk factors and their tangible biological consequences.

The complex interplay between psychiatric illness and sexual dysfunction requires more sophisticated research designs to disentangle cause from effect. It remains difficult to establish whether low desire in a depressed patient is a symptom of the depression, a side effect of medication, or a comorbid condition with a shared pathophysiology (Manohar et al., 2017; Bartlik et al., 2001; Montejo et al., 2018). Longitudinal studies that track sexual function, mood, and biological markers from before the onset of a psychiatric illness, through treatment, and into remission are needed. Such research could clarify the temporal relationship between these conditions and help clinicians make more informed treatment decisions (Pinho et al., 2024).

The development of novel therapeutic agents is another vital frontier. Current pharmacological options are limited, largely consisting of testosterone replacement for hypogonadism and off-label manipulation of psychotropic drugs (Rochira et al., 2022; Zajecka, 2001). The success of flibanserin, a 5-HT1A agonist/5-HT2A antagonist, for female HSDD (Clayton et al., 2010; Jin, 2015) suggests that targeting specific neurotransmitter receptor subtypes could be a fruitful avenue for men as well. Research into agents that selectively modulate the dopamine or melanocortin systems, which are involved in sexual arousal and desire, could lead to the first approved, targeted pharmacotherapies for MHSDD.

Finally, there is a need to better understand the heterogeneity of MHSDD. The disorder is likely not a single entity but a collection of subtypes with different underlying biological causes (Wierman & Cassel, 1998). Future research should aim to identify and validate biological subtypes, for example, distinguishing between hormonally driven MHSDD (e.g., primary hypogonadism), neurotransmitter-based MHSDD (e.g., related to primary dopaminergic hypoactivity), and iatrogenic forms. The identification of reliable biomarkers—be they genetic, endocrine, or neuroimaging-based—would be a monumental step toward personalized medicine, allowing for the stratification of patients and the selection of the most appropriate mechanism-based treatment for each individual. This would represent a significant evolution from the current, often trial-and-error, approach to managing this complex and distressing disorder.

## Conclusion

Male Hypoactive Sexual Desire Disorder is a complex and multifactorial condition, the biological and neurological foundations of which are beginning to be understood with increasing clarity. The synthesis of the available evidence reveals that MHSDD is not a singular dysfunction but rather the clinical endpoint of a variety of potential disruptions across interconnected physiological systems. The integrity of sexual desire in men is contingent upon a delicate equilibrium within the neuroendocrine and central nervous systems, an equilibrium that is vulnerable to endogenous pathology, iatrogenic influences, and the systemic effects of comorbid diseases.

At the core of the biological basis of MHSDD lies the profound influence of the endocrine system. The hypothalamic-pituitary-gonadal axis, through its regulation of testosterone, stands as a primary determinant of male libido (Janmohamed & Bouloux, 2016; Corona et al., 2006). Consequently, conditions leading to hypogonadism, whether from primary testicular failure, central dysfunction, or the natural process of aging, represent a major organic pathway to diminished desire (Rochira et al., 2022; Mooradian & Korenman, 2006). Parallel to this, the role of prolactin, often elevated as a side effect of dopamine-antagonist medications, has been firmly established as a potent suppressor of sexual desire, highlighting the critical interplay between psychiatric treatment and endocrine function (Maguire, 2002; Montejo et al., 2018).

Central neurotransmitter systems, particularly serotonin and dopamine, serve as the primary modulators of sexual motivation and reward. The extensive clinical evidence of decreased libido resulting from the use of serotonergic antidepressants (SSRIs) provides a powerful, albeit iatrogenic, model of serotonin's inhibitory influence on sexual desire (Sonavane et al., 2023; Higgins, 2010; Rosen et al., 1999). Conversely, dopamine's role in driving motivation and reward-seeking behavior positions it as a key excitatory force; its blockade by antipsychotic drugs or its potential dysregulation in depressive states offers a compelling neurochemical explanation for anhedonia and apathy that extends to the sexual domain (Montejo et al., 2020; Blum et al., 2015).

The significant comorbidity of MHSDD with a range of medical and psychiatric disorders underscores its nature as a systemic issue. Chronic illnesses such as renal failure, cardiovascular disease, and diabetes, along with neurological conditions like epilepsy and stroke, create a physiological milieu of inflammation, neuropathy, and vascular compromise that can directly and indirectly dampen sexual desire (Unknown, 2008; Morrell, 1991; Wagner & Sáenz de Tejada, 1998). Most notably, the bidirectional and deeply intertwined relationship between depression and low sexual desire illustrates the inseparability of mental and sexual health (Manohar et al., 2017; Phillips & Slaughter, 2000). Depression can cause low libido as a core symptom, and the distress from low libido can exacerbate depression, creating a vicious cycle that is further complicated by the fact that the primary treatments for one condition often worsen the other (Bartlik et al., 2001; Hirschfeld, 1999).

In conclusion, the biological and neurological understanding of Male Hypoactive Sexual Desire Disorder is one of systems-level dysregulation. It is a condition shaped by hormonal tides, neurotransmitter balances, the integrity of neural circuits governing reward and emotion, and the systemic impact of concurrent diseases and their treatments. While significant gaps remain, particularly in the realms of genetics and specific neural circuit mapping, the existing evidence provides a robust framework for a biopsychosocial approach. This approach acknowledges the powerful influence of biology while recognizing that these systems do not operate in a vacuum but are continuously interacting with an individual's psychological state, interpersonal relationships, and life context. Future progress will depend on research that further elucidates these specific biological pathways, leading to the development of more targeted and effective interventions to restore this fundamental aspect of human health and well-being.



## References

1. Abdo, C. H. N. (2017). Sexualidade e doenças reumáticas. Revista Paulista de Reumatologia. https://doi.org/10.46833/reumatologiasp.2017.16.3.6-12
2. Adi, Y., Ashcroft, D. M., Browne, K. D., Beech, A. R., Fry-Smith, A., & Hyde, C. (2002). Clinical effectiveness and cost-consequences of selective serotonin reuptake inhibitors in the treatment of sex offenders. Health Technology Assessment. https://doi.org/10.3310/hta6280
3. Agarwal, K., Yadav, A. K., Verma, P., & Kaur, B. (2021). DYSTHYMIA AND it’s HOMOEOPATHIC MANAGEMENT. Journal of Emerging Technologies and Innovative Research.
4. Ahemad, M., Ahmad, P. M. F., & Shafaat, M. (2018). Effect of Dalak (Massage) in the Management of Sahar (Insomnia). https://doi.org/10.37591/rrjoush.v5i2.130
5. AL-Ibraheem, M. T. (2018). Cognitive Behavioral Therapy for Incest “Case Study”. Journal of Education and Practice.
6. Albuquerque, A. C. D., Silva, J. R. D., & Silva, J. (2015). The “roundabout Man” Trapped in the “roundabout City” – a Case Report of a Severe Obsessive Compulsive Disorder. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)32056-3
7. Aldweik, A. N., Hussain, K. H., & Alhaj, H. (2023). Can Functional Visual Loss Occur in an Older Adult Patient With a History of Stroke: A Case Report. BJPsych Open. https://doi.org/10.1192/bjo.2023.335
8. Alexander, B. (1993). Disorders of sexual desire: diagnosis and treatment of decreased libido.. PubMed.
9. Alexander, J. L., Dennerstein, L., Woods, N. F., McEwen, B. S., Halbreich, U., Kotz, K., & Richardson, G. (2007). Role of stressful life events and menopausal stage in wellbeing and health. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.7.11s.s93
10. Alexander, J. L., Sommer, B., Dennerstein, L., Grigorova, M., Neylan, T. C., Kotz, K., Richardson, G., & Rosenbaum, R. (2007). Role of psychiatric comorbidity on cognitive function during and after the menopausal transition. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.7.11s.s157
11. Alim, T. N., Lawson, W., Feder, A., Iacoviello, B. M., Saxena, S., Bailey, A., Greene, A., & Neumeister, A. (2012). Resilience to meet the challenge of addiction: psychobiology and clinical considerations.. PubMed.
12. Alkan, A., Öztorun, H. S., Karcı, E., Ürün, Y., Tuncay, G., Yaşar, A., Çınar, E., Aras, S., Varlı, M., Utkan, G., Demirkazık, A., Akbulut, H., & Şenler, F. Ç. (2020). The Impact of Loneliness and Cancer Diagnosis on Cognitive Impairment in Geriatric Patients. Journal of Oncological Sciences. https://doi.org/10.37047/jos.2019-71889
13. Allaz, A. (2017). Dimensions psychologiques de la douleur chronique chez les personnes âgées Psychological components of chronic pain in the elderly.
14. Alloy, L. B., & Abramson, L. Y. (2010). Cyclothymic Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0249
15. Alonso, Y., Miralles, M. C., Mulet, B., & Serret, V. (2007). Asperger's disorder in adulthood: a case report.. PubMed.
16. Andrews, G., Brugha, T., Thase, M. E., Duffy, F. F., Rucci, P., & Slade, T. (2007). Dimensionality and the category of major depressive episode. International Journal of Methods in Psychiatric Research. https://doi.org/10.1002/mpr.216
17. Anghel, L., Boev, M., Stănescu, C., Caramfil, S. M., Luca, L., Mușat, C. L., & Ciubară, A. (2023). Depression in the Diabetic Patient. BRAIN BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE. https://doi.org/10.18662/brain/14.4/526
18. Ansari, S., & Kang, T. K. (2019). Stress of Aged Elderly:A Review. Indian Journal of Health and Wellbeing.
19. Antuña, C. V., Gómez, J. F., Barmadah, S. E., Miranda, M. C. F., Gómez, F. V., & González, F. F. (2008). Fisiopatología y abordaje de la disfunción sexual en pacientes epilépticos. Revista de Neurología. https://doi.org/10.33588/rn.4607.2007574
20. Arafat, S. M. Y. (2017). Dhat Syndrome: Culture Bound, Separate Entity, or Removed. Journal of Behavioral Health. https://doi.org/10.5455/jbh.20170123102726
21. Arias-Falcón, Y., Reyes-Castellano, A. J., & Pequeño-Rondón, M. M. (2020). Síndrome del niño maltratado. Revista electrónica "Dr. Zoilo E. Marinello Vidaurreta".
22. Ariff, K. M., & Hassan, Z. A. (2006). Insomnia: Case Studies In Family Practice.. DOAJ (DOAJ: Directory of Open Access Journals).
23. Arnone, J. M., & Conti, R. P. (2016). Kleine-Levin Syndrome: An Overview and Relevance to Nursing Practice. Journal of Psychosocial Nursing and Mental Health Services. https://doi.org/10.3928/02793695-20160219-07
24. Arredondo-Aldana, K., Mera-Posligua, M. J., & Alencastro, J. A. P. (2021). Trastorno Depresivo Persistente y Trastornos de Ansiedad Generalizada Proveniente de un Estrés Post Traumático Crónico: Presentación de un Caso Clínico. Revista Científica Arbitrada en Investigaciones de la Salud GESTAR. https://doi.org/10.46296/gt.v4i8edesp.0027
25. Arroyo, H., Klipstein, K., Ernst, C. L., & Finkel, J. H. (2016). Somatic Symptom and Related Disorders, Including Illness Anxiety, Factitious, Malingering, and Conversion Disorders. https://doi.org/10.1002/9781118654231.ch20
26. Asad, F., Jahangarad, S., & Dorgalaleh, A. (2023). Psychological complications among patients with congenital bleeding disorders. Blood Coagulation & Fibrinolysis. https://doi.org/10.1097/mbc.0000000000001191
27. Athanasou, J. A. (2016). Substance Abuse. SensePublishers eBooks. https://doi.org/10.1007/978-94-6300-657-6_17
28. Aulinas, A., & Webb, S. M. (2014). Health-related quality of life in primary and secondary adrenal insufficiency. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1586/14737167.2014.963559
29. Autor, S. (2002). CÁPSULAS PARA LA VIDA.- ANSIEDAD. Gaceta UNAM (2000-2009).
30. Avari, J., Yuen, G. S., AbdelMalak, B., Mahgoub, N., Kalayam, B., & Alexopoulos, G. S. (2014). Assessment and Management of Late-Life Depression. Psychiatric Annals. https://doi.org/10.3928/00485713-20140306-04
31. Aversa, A., Rocchietti-March, M., Botta, D., Caprio, M., Pezzella, P., Fabbrini, E., Fabbri, A., & Bonifacio, V. (1998). [Pharmacology of male sexual dysfunction].. PubMed.
32. Ayoob, A., & Janakiram, C. (2021). Let's Focus on Frailty. Journal of Indian Association of Public Health Dentistry. https://doi.org/10.4103/jiaphd.jiaphd_93_21
33. Badalyan, О. L., Avakyan, G. N., & Chukanova, A. S. (2016). Reproductive disorders in male patients with epilepsy. DOAJ (DOAJ: Directory of Open Access Journals).
34. Bains, N., Abdijadid, S., & Miller, J. (2021). Major Depressive Disorder (Nursing).
35. Bains, S., & Shah, A. A. (2012). Sexual Side Effects of Antipsychotic Drugs. Advances in Pharmacoepidemiology & Drug Safety. https://doi.org/10.4172/2167-1052.1000109
36. Bal, U., Çakmak, S., & Uğuz, Ş. (2013). Anksiyete Bozukluklarında Cinsiyete Göre Semptom Farklılıkları. Arşiv Kaynak Tarama Dergisi. https://doi.org/10.17827/aktd.13962
37. Balaram, K., Tampi, D. J., & Tampi, R. R. (2022). It’s like she lost her mind overnight. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197521670.003.0022
38. Baldursson, G., Oo, G., & Magnússon, P. (2000). [Hyperkinetic disorder. A review.].. PubMed.
39. Baldwin, D. S., & Foong, T. (2013). Antidepressant drugs and sexual dysfunction. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.bp.112.110650
40. Baldwin, D. S., Ajel, K., & Garner, M. (2008). Anxiety disorders. Medicine. https://doi.org/10.1016/j.mpmed.2008.05.002
41. Baldwin, D. S., Mayers, A., & Lambert, A. (2004). Sexual dysfunction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198527480.003.0007
42. Balercia, G., Boscaro, M., Lombardo, F., Carosa, E., Lenzi, A., & Jannini, E. A. (2007). Sexual Symptoms in Endocrine Diseases: Psychosomatic Perspectives. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000099840
43. Bansal, J., Bansal, A., Shahi, M. K., Kedige, S., & Narula, R. (2014). Periodontal Emotional Stress Syndrome: Review of Basic Concepts, Mechanism and Management. Open Journal of Medical Psychology. https://doi.org/10.4236/ojmp.2014.33026
44. Barbeau, G. (2006). La sexualité de la personne âgée et les médicaments. Santé mentale au Québec. https://doi.org/10.7202/030083ar
45. Barnes, T. R. E., & Paton, C. (2011). Do antidepressants improve negative symptoms in schizophrenia?. BMJ. https://doi.org/10.1136/bmj.d3371
46. Barrio, P., Seeman, M. V., & González-Rodríguez, A. (2021). Alcohol and Psychosis: A Narrative Review of the Prevalence, Clinical Manifestations, and Management of Alcohol-related Psychotic Symptoms. Current Psychiatry Research and Reviews. https://doi.org/10.2174/2666082217666210602111739
47. Bartlik, B., Jh, K., Legere, R., Villaluz, J., Kossoy, A., & Aj, G. (2001). Sexual dysfunction secondary to depressive disorders.. PubMed.
48. Batra, S., Anand, A., Singh, A., & Verma, S. (2023). Chronic Mania: Diagnostic Dilemma and the Need for Addition in Nosology. Cureus. https://doi.org/10.7759/cureus.38703
49. Baum, R., & Campo, J. V. (2022). Medically Unexplained Symptoms. Pediatric Care Online. https://doi.org/10.1542/aap.ppcqr.396501
50. Bayle, G. (2008). Travail de fin de cure et névrose d'intendance. Revue française de psychanalyse. https://doi.org/10.3917/rfp.721.0009
51. Bazhmin, M. (2021). Unusual drug-resistant psychotic state with epilepsy manifestations, cognitive deterioration and muscular atrophy - case report. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.648
52. Behrman, S., & Crockett, C. (2023). Severe mental illness and the perimenopause. BJPsych Bulletin. https://doi.org/10.1192/bjb.2023.89
53. Bellinghieri, G., Santoro, D., Satta, E., & Savica (2008). Erectile dysfunction and quality of life in patients with chronic renal failure.
54. Benbow, S., & Jagus, C. E. (2002). Sexuality in older women with mental health problems. Sexual & Relationship Therapy. https://doi.org/10.1080/14681990220149068
55. Benedict, C., & Nelson, C. J. (2016). Psychological assessment of patients with ED. https://doi.org/10.1002/9781118746509.ch14
56. Berg, V. D. S., Ch, R., & Sj, R. (2015). [Gradually increasing apathy and self-neglect in a 29-year-old man].. PubMed.
57. Bertelli, M. O., Groef, J. D., & Rondini, E. (2019). Phenomenological Psychopathology of Neurodiversity. https://doi.org/10.1093/oxfordhb/9780198803157.013.100
58. Bertodo, T. D. S., Gross, M. S., & Maldaner, E. B. (2018). TRANSTORNOS BIPOLAR E DEPRESSIVO: UMA REVISÃO DOS ASPECTOS CONCEITUAIS.
59. Betsi, G., Goulia, P., Sandhu, S., & Xekouki, P. (2024). Puberty suppression in adolescents with gender dysphoria: an emerging issue with multiple implications. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2024.1309904
60. Bezerra, E. D. L., & Zimmermann, M. (2015). DISTÚRBIOS COMPORTAMENTAIS EM CÃES: Ansiedade por Separação.
61. Bibi, E. S. D. M. (2021). AN OVERVIEW OF POST WAR SOCIAL PROBLEMS IN SYRIA. Pakistan Journal of International Affairs. https://doi.org/10.52337/pjia.v2i2.63
62. Bilous, R., & Donnelly, R. (2010). Sexual Problems in Diabetes. https://doi.org/10.1002/9781444391374.ch22
63. Bjorvatn, B., Jernelöv, S., & Pallesen, S. (2021). Insomnia – A Heterogenic Disorder Often Comorbid With Psychological and Somatic Disorders and Diseases: A Narrative Review With Focus on Diagnostic and Treatment Challenges. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2021.639198
64. Blay, S. L. (2011). A Case of Major Depressive Disorder and Symptoms of Polycystic Ovary Syndrome Responding to Escitalopram. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.11l01183
65. Blazer, D. G., & Hybels, C. F. (2005). Origins of depression in later life. Psychological Medicine. https://doi.org/10.1017/s0033291705004411
66. Blum, K., Badgaiyan, R. D., & Gold, M. S. (2015). Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics.. Cureus. https://doi.org/10.7759/cureus.290
67. Blumenfield, M., & Tiamson, M. L. A. M. (2002). Consultation/Liaison Psychiatry: A Practical Guide.
68. Blumenthal, J. A., & Lett, H. S. (2005). Depression and Cardiac Risk. Journal of Cardiopulmonary Rehabilitation. https://doi.org/10.1097/00008483-200503000-00005
69. Bonnet, M. H., & Arand, D. L. (2008). Chronic insomnia. CRC Press eBooks. https://doi.org/10.3109/9780203091715-12
70. Borges, M. A., Menezes, I. C. B. D., Bessa, I. G., Correia, G. D. S., Dib, M. C. R. E., Falcão, R. J., & Moraes, L. U. (2021). Sexual dysfunction associated with neurological disorders in men aged 19 to 44 years. Sao Paulo Medical Journal. https://doi.org/10.5327/1516-3180.164
71. Bourdeanu, L., Hein, M. J., & Liu, E. A. (2015). Insomnia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190244330.003.0011
72. Boyd, R. (2022). What is a ‘Social Problem’ in Geriatrics?. Routledge eBooks. https://doi.org/10.4324/9781003284918-12
73. Bravo, B., González, S. M. B., Portilla, N. O., Laynez, M. E. G., Gutiérrez, N. S., & Sánchez, F. G. (2024). Schizophreniform disorder. Clinical manifestations and diagnosis. Purposely a case. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1542
74. Bravo, C. P. (2007). SEXUALIDADE DEPRESSIVA: REALIDADE PRESENTE E FUTURA. Revista Brasileira de Sexualidade Humana. https://doi.org/10.35919/rbsh.v18i1.425
75. Bricou, O., Taïeb, O., Baubet, T., Gal, B., Guillevin, L., & Moro, M. R. (2006). Stress and Coping Strategies in Systemic Lupus Erythematosus: A Review. NeuroImmunoModulation. https://doi.org/10.1159/000104856
76. Brinkmann, B. H. (2021). Mental Disorder Issues in People.
77. Brodsky, M., & Hansen, A. (2017). Pain. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190466268.003.0012
78. Broglin, D. (2009). Troubles sexuels chez les patients épileptiques. Epilepsies. https://doi.org/10.1684/epi.2009.0277
79. Bromberger, J. T. (1998). Gender and Depression. https://doi.org/10.1093/oso/9780195113969.003.0003
80. Bronner, G., & Vodušek, D. B. (2011). Management of sexual dysfunction in Parkinson’s disease. Therapeutic Advances in Neurological Disorders. https://doi.org/10.1177/1756285611411504
81. Broomfield, N. M., Wild, M. R., & Espie, C. A. (2008). Assessment and treatment of insomnia in later life. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780198569459.003.0011
82. Brouillette, M., & Paris, J. (1991). The Dangerousness Criterion for Civil Commitment: The Problem and a Possible Solution*. The Canadian Journal of Psychiatry. https://doi.org/10.1177/070674379103600409
83. Broul, M., Kučerová, P., Jozífková, E., & Žižková, K. (2024). Treatment of thyroid disorder supported by 5-phosphodiesterase inhibitors improved erectile dysfunction in patients with hypo- and hyperthyroidism.. PubMed.
84. Brown, T. A., & Lawrence, A. E. (2008). Generalized Anxiety Disorder and Obsessive-Compulsive Disorder. https://doi.org/10.1093/oso/9780195374216.003.0006
85. Brüne, M. (2008). Substance Abuse and Substance Dependence. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199207688.003.0010
86. Brüne, M. (2015). Forensic aspects of psychiatric disorders. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780198717942.003.0021
87. Bucher, J., & Christ, E. (2014). Klinik und Diagnose von Hypogonadismus und Andropause. Therapeutische Umschau. https://doi.org/10.1024/0040-5930/a000505
88. Bucks, R. S., & Loewenstein, D. (1999). Neuropsychological assessment. https://doi.org/10.1093/oso/9780192628152.003.0007
89. Buljan, D. (2009). Psychological and psychiatric factors of chronic pain.
90. Busto, E. D., Stoddard, F. R., & Cruz, J. S. (2016). Sexual Behaviors in Sleep. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780190245863.003.0003
91. Butler, D. J. (1993). Men sexually abused in childhood. Sequelae and implications for the family physician. Archives of Family Medicine. https://doi.org/10.1001/archfami.2.1.29
92. Cabello-Santamaría, F., & Palacios, S. (2012). Actualización sobre el trastorno del deseo sexual hipoactivo femenino. Progresos de Obstetricia y Ginecología. https://doi.org/10.1016/j.pog.2011.11.012
93. Cadoret, R. J., & Winokur, G. (1972). Genetic Principles in the Classification of Affective Illnesses. International Journal of Mental Health. https://doi.org/10.1080/00207411.1972.11448572
94. Caeiro, L., Ferro, J. M., Melo, T. P. E., Canhão, P., & Figueira, M. L. (2013). Supplementary Material for: Post-Stroke Apathy: An Exploratory Longitudinal Study. Figshare. https://doi.org/10.6084/m9.figshare.5124829
95. Calabrò, R. S. (2022). Post-stroke Sexual Dysfunction in Men: Epidemiology, Diagnostic Work-up, and Treatment.. PubMed.
96. Calabrò, R. S., & Manuli, A. (2022). Sexual Function and Disability in the Neurorehabilitation Setting: An Urgent Need for a Multidisciplinary Approach.. PubMed.
97. Calabrò, R. S., Gervasi, G., & Bramanti, P. (2011). Male Sexual Disorders Following Stroke: An Overview. International Journal of Neuroscience. https://doi.org/10.3109/00207454.2011.600647
98. Calabrò, R. S., Luca, R. D., Manuli, A., Portaro, S., Naro, A., & Quattrini, F. (2019). Towards Improving Post-SSRI Sexual Dysfunction by Using Nutriceuticals: Lessons from a Case Study. Journal of Sex & Marital Therapy. https://doi.org/10.1080/0092623x.2018.1556755
99. Calderón, G. (2021). Adicción al sexo. Revista Española de Drogodependencias.
100. Camacho, M., Moura, A. R., & Oliveira‐Maia, A. J. (2018). Compulsive Sexual Behaviors Treated With Naltrexone Monotherapy. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.17l02109
101. Campana, R. (2017). The Basics of Addiction. MOJ Addiction Medicine & Therapy. https://doi.org/10.15406/mojamt.2017.03.00046
102. Campbell, M., & Stein, D. J. (2014). Hypersexual disorder in general practice. South African Medical Journal. https://doi.org/10.7196/samj.8409
103. Campoy, A. T., Rotger, M. Y., Gutiérrez, L. R. D. L. H., González, S. M. B., & Pastorelli, R. V. (2011). Dificultad diagnóstica de los trastornos de personalidad. A propósito de un caso.. Psicologia.com.
104. Cao, F., Salem, H., Nagpal, C., & Teixeira, A. L. (2017). Prolonged delirium misdiagnosed as a mood disorder. Dementia & Neuropsychologia. https://doi.org/10.1590/1980-57642016dn11-020014
105. Caraiane, A., Szalontay, A. S., Macovei, L. A., Romila, A., Indrei, L. L., Decusară, M., & Tarc, T. (2018). Oral-Facial Manifestations Caused by the Use of Psychotropic Medication in Psychiatric Patients. Revista de Chimie. https://doi.org/10.37358/rc.18.6.6374
106. Caretta, F., & Petrini, M. (2006). La contenzione in ambito geriatrico. RIVISTA SPERIMENTALE DI FRENIATRIA. https://doi.org/10.1400/67163
107. Carneiro, C., Chaves, M. L. D. S. C., Verardino, G. C., Drummond, A., Ramos‐e‐Silva, M., & Carneiro, S. (2011). Fatigue in psoriasis with arthritis.. PubMed.
108. Carta, M. G., & Preti, A. (2017). Adjustment Disorder and Its Clinical Management. https://doi.org/10.2310/psych.13027
109. Carvajal-Lohr, A., Flores‐Ramos, M., Montejo, S. I., & Vidal, C. G. (2016). Los trastornos de ansiedad durante la transición a la menopausia. Perinatología y Reproducción Humana. https://doi.org/10.1016/j.rprh.2016.03.003
110. Castaño-Cárcamo, M., Escobar-Córdoba, F., & Castro, J. R. D. (2014). [Restless Legs Syndrome : A Threat to the quality of life].. PubMed.
111. Cavanaugh, R. M. (2002). Evaluating Adolescents With Fatigue. Pediatrics in Review. https://doi.org/10.1542/pir.23-10-337
112. Chang, H., & Chow, C.-C. (2011). The treatment of fetishism in an adolescent with attention deficit hyperactivity disorder.. PubMed.
113. Chaouloff, F., Dubreucq, S., Matias, I., & Marsicano, G. (2013). Physical activity feel-good effect:The role of endocannabinoids. Routledge eBooks. https://doi.org/10.4324/9780203132678-12
114. Charbonnier, V., Roy, A., Seegmüller, C., Gautier, A., & Gall, D. L. (2011). Étude d'un cas de syndrome dysexécutif à prédominance cognitive chez un enfant présentant une épilepsie frontale symptomatique. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2011.0161
115. Charmaz, K. (2007). Chronic Illness and Disability. The Blackwell Encyclopedia of Sociology. https://doi.org/10.1002/9781405165518.wbeosc035
116. Chatterjee, S., group, C. A., Khasnobis, M., group, R., Roy, S., & group, P. P. M. (2022). Symposium. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.341842
117. Chavan, R., Gosavi, M., Baviskar, M., & Goyal, N. P. (2023). Depression Detection using AI, ML and NLP. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-8886
118. Chen, W.-H., Chu, M.-Y., & Lin, Y.-C. (2017). Sexual Behavior, Function and Satisfaction in Headache Associated with Sexual Activity: A Systematic Review of Literature. Advances in Sexual Medicine. https://doi.org/10.4236/asm.2017.72005
119. Chen, Y.-S. (2012). Association between chronic insomnia and depression in elderly adults. Journal of the Chinese Medical Association. https://doi.org/10.1016/j.jcma.2012.04.001
120. Chiliza, B., & Vythilingum, B. (2011). Consultation liaison psychiatry in Africa – essential service or unaffordable luxury?. African Journal of Psychiatry. https://doi.org/10.4314/ajpsy.v14i4.1
121. Cho, C. (2005). Clinical Implications of Aging and Characteristics of Illnesses of the Aged. Journal of the Korean Medical Association. https://doi.org/10.5124/jkma.2005.48.1.15
122. Chojnowski, J., Więdłocha, M., & Mosiołek, A. (2017). Zaburzenia seksualne u pacjentów ze schizofrenią.
123. Christensen, B., Prentice, R., Al‐Ani, A., Zhang, E., Bedell, A., & Rubin, D. T. (2022). Self-Reported Failure to Address Sexual Function in Patients With Inflammatory Bowel Disease by Gastroenterologists: Barriers and Areas for Improvement. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izac025
124. Chughtai, B., Sciullo, D., Khan, S. A., Rehman, H., Mohan, E., & Rehman, J. (2009). etiology, diagnosis & management ofHypersexuality: a review. The Internet Journal of Urology.
125. Clark, J. D., Rager, D. R., & Calpin, J. P. (1997). Animal well-being. II. Stress and distress.. PubMed.
126. Clark, J. D., Rager, D. R., & Calpin, J. P. (1997). Animal well-being. III. An overview of assessment.. PubMed.
127. Clayton, A., Dennerstein, L., Pyke, R. E., & Sand, M. (2010). Flibanserin: A Potential Treatment for Hypoactive Sexual Desire Disorder in Premenopausal Women. Women s Health. https://doi.org/10.2217/whe.10.54
128. Coghill, D., Bonnar, S., Duke, S., Graham, J., & Seth, S. (2009). Obsessive compulsive disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199234998.003.0020
129. Cohen, L. J., & Brody, D. S. (2015). Frontotemporal Dementia‐Like Syndrome Following Recall of Childhood Sexual Abuse. Journal of Traumatic Stress. https://doi.org/10.1002/jts.22016
130. Cohler, B. J., & Levy, R. M. (2014). El momento histórico en el análisis de los hombres gais. Aperturas psicoanalíticas: Revista de psicoanálisis.
131. Colón‐Emeric, C., Whitson, H. E., Pavon, J. M., & Hoenig, H. (2013). Functional decline in older adults.. PubMed.
132. Combs, S., Kluger, B. M., & Kutner, J. S. (2013). Research Priorities in Geriatric Palliative Care: Nonpain Symptoms. Journal of Palliative Medicine. https://doi.org/10.1089/jpm.2013.9484
133. Compton, M. T., & Broussard, B. (2010). Psychosocial Treatments for Early Psychosis. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195372496.003.0016
134. Conaglen, H. M., & Conaglen, J. V. (2013). Drug-induced sexual dysfunction in men and women. Australian Prescriber. https://doi.org/10.18773/austprescr.2013.021
135. Conway, K. P., Montoya, I. D., & Compton, W. M. (2007). Lifetime Psychiatric Comorbidity of Illicit Drug Use Disorders. The Psychiatric times.
136. Cope, T., & Baguley, D. (2009). Is musical hallucination an otological phenomenon? a review of the literature. Clinical Otolaryngology. https://doi.org/10.1111/j.1749-4486.2009.02013.x
137. Coppen, A., & Swade, C. (1988). 5-HT and Depression: the Present Position. https://doi.org/10.1007/978-1-349-09506-3_9
138. Corona, G., Forti, G., & Maggi, M. (2006). Il desiderio sessuale ipoattivo nell'uomo: il ruolo dell'andrologo.
139. Corona, G., Mannucci, E., Petrone, L., Fisher, A. D., Balercia, G., Scisciolo, G. D., Pizzocaro, A., Giommi, R., Chiarini, V., Forti, G., & Maggi, M. (2006). Psychobiological Correlates of Delayed Ejaculation in Male Patients With Sexual Dysfunctions. Andrology. https://doi.org/10.2164/jandrol.05154
140. Correll, C. U. (2013). The Prevalence of Negative Symptoms in Schizophrenia and Their Impact on Patient Functioning and Course of Illness. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.12045tx1c
141. Cortés, M. D. C. M. (2013). Análisis evolutivo y valoración neuropsicológica integral de pacientes con deterioro cognitivo leve o enfermedad de Alzheimer..
142. Cosman, D., & Nemeş, B. (2015). The Management of Suicidal Patients. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)30082-1
143. Costa, S. C. D., Coutinho, B., & Novo, T. (2012). P-274 - Attention deficit hyperactivity disorder in adults: what is the approach?. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)74441-3
144. Courtois, F., Alexander, M., & McLain, A. (2017). Women's Sexual Health and Reproductive Function After SCI. Topics in Spinal Cord Injury Rehabilitation. https://doi.org/10.1310/sci2301-20
145. Cuevas, P., Camacho, J. C. F. D. C., Villamizar, R., Rosario, I., Parres, R., Mendoza, J., & Rodríguez, D. L. (2000). Cambios en la psicopatología del trastorno limítrofe de la personalidad, en los pacientes tratados con psicoterapia psicodinámica. Salud Mental.
146. Cyrańska-Chyrek, E., Grzymisławska, M., & Ruchała, M. (2017). Pułapki w diagnostyce incydentaloma nadnerczy. Endokrynologia Polska. https://doi.org/10.5603/ep.2017.0028
147. Czajkowska‐Malinowska, M., & Cofta, S. (2014). Obturacyjny bezdech senny i jego społeczne następstwa.
148. Călin, A. M., Debita, M., Ciurcanu, O. E., Scutariu, M. M., & Szalontay, A. S. (2017). Xerostomia and Hyposalivation in Patients with Physical and Psychological Disabilities. Revista de Chimie. https://doi.org/10.37358/rc.17.10.5902
149. Dahm, K. T., Holte, H. H., Dalsbø, T. K., Straumann, G. H., & Reinar, L. M. (2017). Effect of Physical Activity without Use of Antipsychotics Compared to Physical Activity and Antipsychotics for Patients with Active Psychosis: A Systematic Review [Internet].
150. Daley, D. C., & Douaihy, A. (2006). The Recovery Process for Addiction and Mood Disorders. https://doi.org/10.1093/oso/9780195311297.003.0004
151. Daley, D. C., & Douaihy, A. (2019). Managing Cravings and Urges to Use Substances. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926717.003.0009
152. Daley, D. C., & Douaihy, A. (2019). Substance-Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0002
153. Dallon, C., & Abraham, G. (2009). [Psychosis and sexuality].. PubMed.
154. Delev, D., Kostadinova, I., Kostadinov, I., & Ubenova, D. K. (2009). Physiological and clinical characteristics of andropause.. Folia Medica.
155. DeLuca, G. C., & Bartleson, J. D. (2010). When and How to Investigate the Patient with Headache. Seminars in Neurology. https://doi.org/10.1055/s-0030-1249221
156. Demb, H. B., Papola, P., Rosenberg, R. L., & Plum, E. (1998). A Typical Children Followed-Up in Adolescence. Clinical Child Psychology and Psychiatry. https://doi.org/10.1177/1359104598032011
157. Derman, E., Whitesman, S., Dreyer, M., Patel, D., Nossel, C., & Schwellnus, M. (2010). Healthy lifestyle interventions in general practice: Part 12: Lifestyle and depression. South African Family Practice. https://doi.org/10.1080/20786204.2010.10873989
158. Dhobe, S., Gujar, S., & Sc, M. (2021). Prevalence of Associated Factors of Depressive Symptoms among School Going Children’s. Indian Journal of Forensic Medicine & Toxicology. https://doi.org/10.37506/ijfmt.v15i1.13470
159. Diarra, E., Jedynak, C. P., & Verny, M. (2008). [Tremor in the elderly].. PubMed. https://doi.org/10.1684/pnv.2008.0139
160. Dias, I. M., Maia, I. D., Mello, L. M. R. D., Leite, I. C. G., & Leite, F. P. P. (2014). Evaluation of correlation among sleep bruxism and depression levels, chronic pain and nonspecific physical symptoms according to axis II of the Research Diagnostic Criteria/Temporomandibular disorders. RSBO Revista Sul-Brasileira de Odontologia.
161. Dias, R. D. S., Kerr-Corrêa, F., Torresan, R. C., & Santos, C. H. R. D. (2006). Transtorno bipolar do humor e gênero. Archives of Clinical Psychiatry (São Paulo). https://doi.org/10.1590/s0101-60832006000200008
162. Dickstein, D. R., Edwards, C. R., Rowan, C., Avanessian, B., Chubak, B., Wheldon, C. W., Simoes, P., Buckstein, M., Keefer, L., Safer, J. D., Sigel, K., Goodman, K. A., Rosser, B. R. S., Goldstone, S. E., Wong, S.-Y., & Marshall, D. (2024). Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus. Nature Reviews Gastroenterology & Hepatology. https://doi.org/10.1038/s41575-024-00932-1
163. Dikeos, D., & Soldatos, C. R. (2005). The condition of insomnia: Etiopathogenetic considerations and their impact on treatment practices. International Review of Psychiatry. https://doi.org/10.1080/09540260500104466
164. Dobrakowski, P., Pierzchała, K., & Łabuz-Roszak, B. (2013). [Sexual dysfunctions and sexual satisfaction among multiple sclerosis patients].. PubMed.
165. Dolenc, T. J. (2015). Substance Use Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214883.003.0044
166. Doğru, H. Y., Özsoy, A. Z., İşgüder, Ç. K., Özsoy, F., Delibaş, İ. B., & Çakmak, B. (2015). Gebelikte Tekrar Eden İntihar Girişimlerine Rağmen Fatal Seyretmeyen O sesif- Kompulsif Bozukluk:Olgu Sunumu. Gaziosmanpaşa Üniversitesi Tıp Fakültesi Dergisi.
167. Drobek-Gilowska, A., Kowalik, S., & Studziński, T. (2002). Obnizona wydolnosc wysilkowa koni - przyczyny i diagnozowanie.
168. Dubatova, I. V., Antsyborov, A. V., Kalinchuk, A. V., & Antsyborov, L. A. (2020). Oppositional Defiant Disorder in Childhood and Adolescence. Interactive science. https://doi.org/10.21661/r-551677
169. Dugue, M., & Neugroschl, J. (2002). Anxiety disorders. Helping patients regain stability and calm.. PubMed.
170. Durán, L. V. B., Navarrete, K. S. H., & Salas, M. F. (2023). Actualización del trastorno dismórfico corporal. Revista Medica Sinergia. https://doi.org/10.31434/rms.v8i2.967
171. Dwyer, A., Smith, N., & Quinton, R. (2019). Psychological Aspects of Congenital Hypogonadotropic Hypogonadism. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2019.00353
172. D’cruz, M., Andrade, C., & Rao, T. S. (2020). The Expression of Intimacy and Sexuality in Persons With Dementia. Journal of Psychosexual Health. https://doi.org/10.1177/2631831820972859
173. D’Souza, R. S., & Hooten, W. M. (2019). Somatic Syndrome Disorders.
174. Elliott, S. (2002). Orgasmic and ejaculatory problems in clinical practice. Journal of Sexual & Reproductive Medicine. https://doi.org/10.4172/1488-5069.1000032
175. Enrique, P. M. L., Gloria, A. S., Efraín, S. C. J., & Luis, G. A. J. (2019). Latencia diagnóstica en la enfermedad de Parkinson y su relación con los síntomas prodrómicos motores y no motores. eNeurobiología.
176. Errante, P. R. (2022). Canine Cognitive Dysfunction Syndrome a Challenge in Treatment and Improvement in Quality Life of Older Dogs. International Journal of Zoology and Animal Biology. https://doi.org/10.23880/izab-16000424
177. Escamilla-Soto, M. C., Montoya-Rojas, Y. A., Quintero-Cadavid, C. P., & Valencia, J. G. (2024). Trastornos depresivos y ansiosos en población con discapacidad intelectual. IATREIA. https://doi.org/10.17533/udea.iatreia.269
178. Esfahani, M. N., Kjbaf, M. B., & Abedi, M. R. (2015). Evaluation and Comparison of the Effects of Time Perspective Therapy, Acceptance and Commitment Therapy and Narrative Therapy on Severity of Symptoms of Obsessive-Compulsive Disorder. Journal of the Indian Academy of Applied Psychology.
179. Espinoza, H., & Vicente, J. (2015). Trastorno por ansiedad en paciente de 46 años de escolarización medio con tratamiento psicoterapéutico en modelo psicológico cognitivo conductual..
180. Fabre, L. F., Clayton, A. H., Smith, L. C., Goldstein, I. M., & Derogatis, L. R. (2013). Association of Major Depression With Sexual Dysfunction in Men. Journal of Neuropsychiatry. https://doi.org/10.1176/appi.neuropsych.12010004
181. Fachrudin, D. (2019). Episode Depresif Berat dengan Gejala Psikotik (Studi Kasus dalam Perspektif Psikologi dengan Pendekatan Teori Kognitif Beck). Tunas Medika Jurnal Kedokteran & Kesehatan.
182. Fadem, B. H., & Simring, S. S. (1998). High-Yield Psychiatry.
183. Falcão, F. A., Santos, A. L. D., Barbosa, D. C. B., & Santos, T. R. D. (2022). Responsabilidade civil no erro médico e dano moral. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.25
184. Falk, A., Joseph, R., Smith, S., & Wilk, A. (2023). Mood and Anxiety Disorders: Major Depressive Disorder.. PubMed.
185. Favrat, B., Guessous, I., Gonthier, A., & Cornuz, J. (2015). [Prolonged or chronic fatigue of unknown origin].. PubMed.
186. Fekih‐Romdhane, F., Abassi, B., Baccar, F., Cheour, M., Sana, E., & Damak, R. (2024). The Impact of Psychotropics on Sexuality: A Literature Review. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1600
187. Feliciano, R., & Alfonso, C. A. (1997). Sexual Side Effects of Psychotropic Medication—Diagnosis, Neurobiology, and Treatment Strategies. International Journal of Mental Health. https://doi.org/10.1080/00207411.1997.11449389
188. Feng, G. (2008). Relationship Study between Chronic Fatigue Syndrome and Emotional Factors. Liaoning Zhongyiyao Daxue xuebao.
189. Ferenidou, F., Mourikis, I., Sotiropoulou, P., & Vaidakis, N. (2020). Zolpidem related persistent genital arousal disorder: An interesting case. Psychiatriki. https://doi.org/10.22365/jpsych.2019.304.339
190. Fernández, A. A., Martín, Á. P., Martínez, M. I., Bustillo, M. A., Hernández, F. B., Labrado, J. D. L. C., Peñas, R. D.-D., Rivas, E. G., Delgado, C. P., Redondo, J. R., & Giménez, J. R. R. (2009). Chronic fatigue syndrome: aetiology, diagnosis and treatment. BMC Psychiatry. https://doi.org/10.1186/1471-244x-9-s1-s1
191. Finsterer, J., & Zarrouk‐Mahjoub, S. (2013). Fatigue in Healthy and Diseased Individuals. American Journal of Hospice and Palliative Medicine®. https://doi.org/10.1177/1049909113494748
192. Fisher, R. L. (2022). Premenstrual Syndrome (PMS). CRC Press eBooks. https://doi.org/10.1201/9781003039235-42
193. Fitten, L. J. (2015). Psychological Frailty in the Aging Patient. Nestlé Nutrition Institute Workshop series. https://doi.org/10.1159/000382060
194. Fitzgerald, C., & Patten, S. B. (2008). Is Multiple Sclerosis Patient Depressed, Stressed, or Both? How to Sort through Overlapping Symptoms and Provide Appropriate Treatment. Current psychiatry.
195. Flores, C. (2010). FACTORES QUE INFLUYEN EN LA ADICCIÓN ADOLESCENTE. Contribuciones a las Ciencias Sociales.
196. FM, P., & FP, J. (2015). Persistent Genital Arousal Disorder as a Dissociative Trauma Related Condition Treated with Brainspotting A Successful Case Report. International Journal of School and Cognitive Psychology. https://doi.org/10.4172/2469-9837.1000s1-002
197. Follingstad, D. R. (2009). The Impact of Psychological Aggression on Women's Mental Health and Behavior. Trauma Violence & Abuse. https://doi.org/10.1177/1524838009334453
198. Forero, M. H., Tautiva, H., & Galindo, L. (2014). Subdiagnóstico de la fibromialgia en hombres: revisión de la literatura y reporte de un caso. Revista Colombiana de Medicina Física y Rehabilitación. https://doi.org/10.28957/rcmfr.v24n2a9
199. Franjić, S. (2019). Female Sexual Dysfunction. https://doi.org/10.36811/ijrmsh.2019.110003
200. Franjić, S. (2023). Child Abuse and Neglect is a Serious Problem in Every Society. Deleted Journal. https://doi.org/10.33140/jre.01.01.03
201. Frazer, D. W., Hinrichsen, G. A., & Jongsma, A. E. (1998). The Older Adult Psychotherapy Treatment Planner.
202. Frieling-Sonnenberg, W. (1997). -At an age when patients need help, illness is promoted by the structures of geriatric care.. PubMed.
203. Frías, Á., Palma, C., Fernández, I. A., & Cirera, B. M. (2013). Propósito de un Caso: Masoquismo sexual: controversias etiopatogénicas y nosológicas a propósito de un caso. Cuadernos de medicina psicosomática y psiquiatria de enlace.
204. Fujita, Κ., Terada, H., & Lz, L. (1997). [Male sexual insufficiency].. PubMed.
205. Fukumori, R. H., Rocha, P. M., & Pires, G. M. (2024). Hipoadrenocorticismo em cão. PubVet. https://doi.org/10.31533/pubvet.v18n03e1558
206. Führmann, F., Rößner-Ruff, V., Friedrich, K. J., Krieger, J. E., Hauser, C., Altunöz, U., Ziegenbein, M., & Graef-Calliess, I. (2021). „Geschlechterspezifische“ Unterschiede bei depressiven Erkrankungen? Untersuchung von „nicht-typischen“ Symptomen und Einflussfaktoren - Ergebnisse der „Male Depression“-Studie. Das Gesundheitswesen. https://doi.org/10.1055/s-0041-1732749
207. Galbán, L. Y. P., Rodríguez, L. C., Cruz, M. P. D. L., López, O. L. B., & Álvarez, M. G. (2000). Trastornos múltiples de la inclinación sexual. Presentación de un caso. Revista Archivo Médico de Camagüey.
208. Galderisi, S. (2012). W04-03 - Psychosocial functioning - relationship with symptoms and cognitive impairment. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)75680-8
209. Ganasan, S. (2019). Managing depression in the primary care setting. Journal of Prescribing Practice. https://doi.org/10.12968/jprp.2019.1.8.388
210. Garcia, M. O., Garnica, V. M., López, M. A., Leon, J. R. D., & Marín, S. G. (2017). Somatic-type delusional disorder and comorbidity mood disorder. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.353
211. Gauthier, C. (2010). [Sexual abuse: a cause for psychosomatic illnesses].. PubMed.
212. Genazzani, A. D., Ricchieri, F., Lanzoni, C., Strucchi, C., & Jasonni, V. M. (2006). Diagnostic and Therapeutic Approach to Hypothalamic Amenorrhea. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1365.009
213. Giacomo, E. D., Alamia, A., Cicolari, F., Cimolai, V., & Clerici, M. (2014). [Sexual abuse in adulthood: when psychic and somatic suffering merge].. PubMed. https://doi.org/10.1708/1600.17454
214. Giacomo, E. D., Moretti, F., Colmegna, F., & Clerici, M. (2023). Obsessive–compulsive disorder as the onset of bipolar disorder in adolescence. Bipolar Disorders. https://doi.org/10.1111/bdi.13373
215. Giuliano, F., & Hellstrom, W. J. (2008). The pharmacological treatment of premature ejaculation. BJU International. https://doi.org/10.1111/j.1464-410x.2008.07719.x
216. Glucksman, M. L., & Kramer, M. (2017). Manifest Dream Content as a Predictor of Suicidality. Psychodynamic Psychiatry. https://doi.org/10.1521/pdps.2017.45.2.175
217. Godiawala, S. P., Parikh, M., & Kumar, R. (2024). Unraveling the Diagnostic Challenge: A Case Report on Disruptive Mood Dysregulation Disorder. Indian Journal of Clinical Psychiatry.. https://doi.org/10.54169/ijocp.v4i02.118
218. Goldfinger, C., & Pukall, C. F. (2011). Sexual Pain Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-916-1_12
219. Goldmeier, D., & Andrews, S. (2016). Persistent Genital Arousal Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780190245863.003.0008
220. Golightly, L., & Young, A. H. (1999). Sex hormones and mental health. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.5.2.126
221. Golubtsova, L. I., & Vasil'chenko, G. S. (1988). [Sexual disorders in women with slowly progressing schizophrenia].. PubMed.
222. González, C., Betés, M., López‐Muñoz, F., & Martín, J. D. D. M. (2011). Aportaciones de la psicofarmacología al tratamiento de los trastornos de la personalidad (II) = Contributions of psychopharmacology for the treatment of personality disorders (II: grupos farmacológicos empleados en el tratamiento de los trastornos de personalidad = pharmacological groups employed in the treatment of the disorders of personality /. Edupsykhé Revista de Psicología y Educación. https://doi.org/10.57087/edupsykhe.v10i2.3852
223. González, S. B., Portilla, N. O., Jiménez, M. G., García, R. Á., & Sánchez, F. G. (2017). Behavioral disorders in emergencies. Differential diagnosis and treatment. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.519
224. Goodyer, I., Herbert, J., Tamplin, A. K., & Altham, P. M. E. (2000). Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.177.6.499
225. Gooren, L., & Ronde, W. D. (2006). [Some new aspects of the Klinefelter syndrome].. PubMed.
226. Grandner, M. A. (2014). Addressing sleep disturbances: An opportunity to prevent cardiometabolic disease?. International Review of Psychiatry. https://doi.org/10.3109/09540261.2014.911148
227. Grant, I., Sacktor, N., & McArthur, J. C. (2005). HIV neurocognitive disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198526100.003.0035
228. Grant, J. E., Schreiber, L. R., & Odlaug, B. L. (2013). Phenomenology and Treatment of Behavioural Addictions. The Canadian Journal of Psychiatry. https://doi.org/10.1177/070674371305800502
229. Greiner, K. A., & Weigel, J. W. (1996). Erectile dysfunction.. PubMed.
230. Groisman, A. E., & Seminatore, M. L. (2003). Children and Adolescents Who Have Schizophrenia. Pediatrics in Review. https://doi.org/10.1542/pir.24.10.356
231. Gruber, G., Saletu‐Zyhlarz, G., Anderer, P., Metka, M., Huber, J. C., Grätzhofer, E., & Saletu, B. (2007). Insomnia During Menopause. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-115-4_18
232. Gunadeva, N., Murchison, J., Wozniak, N., & Hyer, L. (2023). Case: Schizotypal Personality Disorder- Confusion, Misdiagnosis &amp; Lessons. Clinical Reviews & Cases. https://doi.org/10.33425/2689-1069.1051
233. Gupta, K., Parimal, B. S., & Patel, A. K. (2023). Mindfulness-Based Cognitive Therapy for Coping with Premenstrual Syndrome Distress. Advances in medical diagnosis, treatment, and care (AMDTC) book series. https://doi.org/10.4018/978-1-6684-5088-8.ch010
234. Ha, J.-E., Son, H.-J., Kim, B. Y., Jung, Y.-J., Chun, G.-Y., Kim, J.-H., Kim, M., & Cho, H.-H. (2011). Chronic pelvic pain after hysterectomy in a patient with depressive disorder: A case report. Korean Journal of Obstetrics & Gynecology. https://doi.org/10.5468/kjog.2011.54.9.557
235. Haass, M., & Albus, C. (2014). Psychosoziale Faktoren bei Herzinsuffizienz: Mehr als eine Komorbidität?. Kardiologie up2date. https://doi.org/10.1055/s-0034-1365137
236. Hadi, I., Wijayati, F., Usman, R. D., & Rosyanti, L. (2017). Major Depressive Disorder: A Mini Review. Health Information Jurnal Penelitian. https://doi.org/10.36990/hijp.v9i1.102
237. Hafeza, M. J., Bourjia, H., & Sroura, H. (2020). Functional Neurological Deficit: one of the most controversial diagnosis- case report of a patient with paraplegia. International Journal of Case Reports. https://doi.org/10.28933/ijcr-2020-02-2305
238. Hales, R. E., & Yudofsky, S. C. (1996). Synopsis of psychiatry.
239. Halvorsen, J. G., & Metz, M. E. (1992). Sexual dysfunction, Part I: Classification, etiology, and pathogenesis.. PubMed.
240. Halvorsen, J. G., & Metz, M. E. (1992). Sexual dysfunction, Part II: Diagnosis, management, and prognosis.. PubMed.
241. Hansenne, M., Kjiri, K., Ajamieh, A., & Ansseau, M. (1998). [Clinical case of the month. A case of Munchausen syndrome (factitious disorder)].. PubMed.
242. Harris, D. J. (1983). Psychological aspects of retirement.. PubMed.
243. Hartman, T. O., Dowrick, C., Lam, C. L. K., Fortes, S., Clarke, D. D., & Usta, J. (2019). Medically unexplained symptoms. Routledge eBooks. https://doi.org/10.4324/9780429026386-4
244. Hartmann, U. (1998). [Erectile dysfunction: psychological causes, diagnosis and therapy].. PubMed.
245. Harvey, P. D. (2001). Cognitive impairment in elderly patients with schizophrenia: age related changes. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/1099-1166(200112)16:1+<::aid-gps565>3.0.co;2-v
246. Havrlišan, A. (2017). Sestrinska skrb za osobe s poremećajem raspoloženja.
247. Hayempour, B. J. (2013). The Controversy of Conventional Psychiatric Diagnostics. Journal of Neurological Disorders. https://doi.org/10.4172/2329-6895.1000122
248. Hechtman, L. (1991). Resilience and Vulnerability in Long Term Outcome of Attention Deficit Hyperactive Disorder. The Canadian Journal of Psychiatry. https://doi.org/10.1177/070674379103600606
249. Heft, M. W., & Robinson, M. E. (2017). Somatosensory function in old age. Journal of Oral Rehabilitation. https://doi.org/10.1111/joor.12488
250. Hellhammer, D. H., & Wade, S. E. (1993). Endocrine Correlates of Stress Vulnerability. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000288675
251. Herman, S. H., & Sadovsky, R. (2010). Psychosocial health screening and recognizing early signs of psychosocial distress. Journal of Men s Health. https://doi.org/10.1016/j.jomh.2009.12.003
252. Hernández, G., García, L. H., Baez, I. C., Rodrigo, A. M., Torres, C. D., Gómez-Juanes, R., & Pérez, P. G. (2023). Antiandrogenic treatment of obsessive compulsive neurosis: A case review. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.1961
253. Herpertz, S. C., & Saß, H. (2000). Emotional deficiency and psychopathy. Behavioral Sciences & the Law. https://doi.org/10.1002/1099-0798(200010)18:5<567::aid-bsl410>3.0.co;2-8
254. Herrera-Estrella, M., Izar, E., Luna, K. J., & Cuellar-García, M. (2020). Somatics Symptoms and Depression: A Review. International Neuropsychiatric Disease Journal. https://doi.org/10.9734/indj/2019/v13i230109
255. Higgins, A. (2010). Antidepressant-associated sexual dysfunction: impact, effects, and treatment. Drug Healthcare and Patient Safety. https://doi.org/10.2147/dhps.s7634
256. Hindmarch, I. (1998). The behavioural toxicity of antidepressants. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199807006-00002
257. Hirschfeld, R. M. A. (1999). Care of the sexually active depressed patient.. PubMed.
258. Holster, J., Hawks, E. M., & Ostermeyer, B. (2017). Somatic Symptom and Related Disorders. Psychiatric Annals. https://doi.org/10.3928/00485713-20170308-03
259. Hong, C. (2013). 분과 심포지움 2. 임상 : 새로운 진단체계 DSM-5; 조현병 스펙트럼 및 기타 정신병적 장애,성격장애. 한국심리학회 연차 학술발표논문집.
260. Hood, S., & Kirby, M. (2004). Review: Risk factor assessment of erectile dysfunction. The British Journal of Diabetes. https://doi.org/10.1177/14746514040040030401
261. Houde, S. C., & KAMPFE-LEACHER, R. (1997). Chronic Fatigue Syndrome. The Nurse Practitioner. https://doi.org/10.1097/00006205-199707000-00003
262. Hsu, Y., Huang, H.-C., & Huang, S. (2013). Treatment of premature ejaculation. Urological Science. https://doi.org/10.1016/j.urols.2013.01.004
263. Huda, A. S. (2019). Social factors and health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0013
264. Hybels, C. F., Blazer, D. G., & Steffens, D. C. (2006). Partial remission. A common outcome in older adults treated for major depression.. PubMed.
265. Hyler, S. E., & Remien, R. H. (1998). Using Commercial Films to Teach About AIDS. Journal of Psychiatric Practice. https://doi.org/10.1097/00131746-199807000-00005
266. Häuser, W., Dinkel, A., & Lahmann, C. (2012). Funktionelle gastrointestinale Störungen. Psychiatrie und Psychotherapie up2date. https://doi.org/10.1055/s-0032-1304958
267. Iacovides, A., & Siamouli, M. (2008). Comorbid mental and somatic disorders: an epidemiological perspective. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0b013e328303ba42
268. Iliev, B., & Pavlovska, I. (2021). Analysis of Clinical Features of Patients with Depressive Disorder. Journal of Health Medicine and Nursing. https://doi.org/10.7176/jhmn/92-01
269. Imfeld, C., & Imfeld, T. (2005). [Eating disorders (I)--medical and psychiatric aspects].. PubMed.
270. Iorga, M., Stârcea, I. M., Munteanu, M., & Sztankovszky, L.-Z. (2014). PSYCHOLOGICAL AND SOCIAL PROBLEMS OF CHILDREN WITH CHRONIC KIDNEY DISEASE.
271. Irgebaeva, N., & Akmusaeva, M. (2020). ANXIETY OF THE PERSONEMOTIONAL STATUS. BULLETIN Series Psychology. https://doi.org/10.51889/2020-3.1728-7847.04
272. Is, B., Golovoda, A., Pneumaticos, S. G., & Vlamis, J. (2021). The effect of depression in hospitalization and rehabilitation of patients with spinal cord injury. Acta Orthopaedica Et Traumatologica Hellenica.
273. Isohanni, M., Miettunen, J., & Penttilä, M. (2020). Life span development of schizophrenia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190653279.003.0017
274. Issa, B. A. (2013). Prevalence and Correlates of Depressive Disorders among People Living with HIV/AIDS, in North Central Nigeria. Journal of AIDS & Clinical Research. https://doi.org/10.4172/2155-6113.1000251
275. Itani, R., Soubra, L., Karout, S., Rahme, D., Karout, L., & Khojah, H. M. J. (2022). Primary Dysmenorrhea: Pathophysiology, Diagnosis, and Treatment Updates. Korean Journal of Family Medicine. https://doi.org/10.4082/kjfm.21.0103
276. Iversen, L. L., Iversen, S. D., Bloom, F. E., & Roth, R. H. (2009). Psychedelics. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195380538.003.0606
277. J.Sharma, M. (2019). Work Stress and Emotional Health in Working Women. Think India Journal.
278. Jackowich, R. A., Pukall, C. F., & Goldstein, I. (2020). Persistent Genital Arousal Disorder. https://doi.org/10.1002/9781119482598.ch43
279. Jaffe, S. (2013). Menopause, cessation of menses, vs. “menopause”, a primary brain disorder?. Advances in Bioscience and Biotechnology. https://doi.org/10.4236/abb.2013.46a003
280. Jafferany, M., & Pastolero, P. (2018). Psychiatric and Psychological Impact of Chronic Skin Disease. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.17nr02247
281. Janmohamed, S., & Bouloux, P.-M. (2016). Endocrinology of male sexual dysfunction. https://doi.org/10.1002/9781118746509.ch5
282. Jarząbek‐Bielecka, G., Mizgier, M., & Kędzia, W. (2019). … Not only a sexuological problem. Clinical and Experimental Obstetrics & Gynecology. https://doi.org/10.12891/ceog4656.2019
283. Jevtovic, J., Jovanović, J., Grujicic, M. V. –., & Vujcic, J. (2021). OCCUPATIONAL STRESS IN COMPUTER OPERATORS. Knowledge International Journal.
284. Ji-jun, C. (2005). Male climacteric syndrome and age-related changes of androgen.
285. Jin, J. (2015). Flibanserin for Treating Low Sexual Desire in Women. JAMA. https://doi.org/10.1001/jama.2015.11769
286. Joo, N. (2023). Functional assessment and management of chronic fatigue syndrome. Korean Institute for Functional Medicine. https://doi.org/10.32581/jkifm.2023.6.1.7
287. Jung, S. P., & Lee, K. M. (2007). Chronic Fatigue Syndrome. Yeungnam University Journal of Medicine. https://doi.org/10.12701/yujm.2007.24.1.1
288. Kalayjian, L. A., & Morrell, M. J. (2000). Female Sexuality and Neurological Disease. Journal of Sex Education and Therapy. https://doi.org/10.1080/01614576.2000.11074333
289. Kancherla, N., Vanka, S. C., Pokhrel, S., Shahzadi, R. B., & Pradeep, G. V. D. (2022). The Development of Illness Anxiety Disorder in a Patient After Partial Thyroidectomy. Cureus. https://doi.org/10.7759/cureus.25416
290. Kanyengo, C. W. (2009). Zambia: The challenge of informing blind and deaf clients.
291. Kaplan, H., Sadock, B. J., & Cancro, R. (1991). Comprehensive Textbook of Psychiatry/V.. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-114-9-823_8
292. Karakatsoulis, G. N., Tsapakis, E.-M., & Fountoulakis, K. Ν. (2021). Clinical characteristics and treatment of treatment-resistant bipolar depression. Psychiatriki. https://doi.org/10.22365/jpsych.2021.048
293. Karasu, S. R. (2013). <i>Psychotherapy-Lite:</i> Obesity and the Role of the Mental Health Practitioner. American Journal of Psychotherapy. https://doi.org/10.1176/appi.psychotherapy.2013.67.1.3
294. Karatepe, H. T., Işık, H., Sayar, K., & Yavuz, F. (2010). Menstruation-related recurrent psychotic disorder: a case report. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. https://doi.org/10.5350/dajpn2010230409t
295. Katzman, M. A. (2021). The Diagnosis of Major Depressive Disorder is based on the Person's Reported Experiences and a Mental Status Examination. Journal of Aging and Geriatric Medicine.
296. Keller, M. B., & Berndt, E. R. (2002). Depression treatment: a lifelong commitment?. PubMed.
297. Kessler, T. M., Fowler, C. J., & Panicker, J. N. (2009). Sexual dysfunction in multiple sclerosis. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.9.3.341
298. Khan, A. Y., Kalia, R., Ide, G. D., & Ghavami, M. (2017). What Are Realistic Treatment Goals? Lingering Symptoms Require You to Evaluate Pharmacotherapy and Offer Psychosocial Interventions. Current psychiatry.
299. Kim, M. J., & Han, G. C. (2014). Dizziness Problems in Old Age. Journal of Clinical Otolaryngology Head and Neck Surgery. https://doi.org/10.35420/jcohns.2014.25.1.23
300. King, M. (2007). Sexual problems in medical patients. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543975.011
301. Kirilly, E., Gonda, X., Juhász, G., & Bagdy, G. (2013). Nem pszichiátriai gyógyszerek szorongást és depressziót kiváltó mellékhatásai | Anxiogenic and depressogenic side-effects of non-psychiatric drugs.
302. Kirkby, K. C. (2007). Recognising and Responding to Candidates' Health Needs. ACER Press eBooks.
303. Kochar, M. S., & Patel, A. R. (1999). What is causing your patient's sexual dysfunction?. Postgraduate Medicine. https://doi.org/10.3810/pgm.1999.08.655
304. Kockott, G. X. F. T. (1990). [Impotence].. PubMed.
305. Koehn, C., Palmer, T., & Esdaile, J. M. (2002). Exercise. https://doi.org/10.1093/oso/9780195130560.003.0005
306. Kolla, B., & Hocker, S. E. (2021). Substance Use Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0045
307. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
308. Koçak, Ö., & Koçak, S. (2023). Underrated Diagnosis: Prenatal Depression. Kafkas Journal of Medical Sciences. https://doi.org/10.5505/kjms.2023.21033
309. Krahn, L. E., MD, & Jowsey‐Gregoire, S. G. (2006). Psychiatry. CRC Press eBooks. https://doi.org/10.1201/b21610-26
310. Krarup, T. (1998). [Essential testodynia].. PubMed.
311. Kuoch, K. L. J., Hebbard, G., O’Connell, H. E., Austin, D., & Knowles, S. R. (2019). Urinary and faecal incontinence: psychological factors and management recommendations.. PubMed.
312. Kırca, N., & Öngen, M. (2020). İNFERTİLİTE VE UYKU KALİTESİ ARASINDAKİ İLİŞKİ. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi. https://doi.org/10.38136/jgon.697603
313. Lahey, B. B. (2021). Dimensions of Externalizing Problems. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197607909.003.0004
314. Lam, R. W. (2012). Clinical features and diagnosis. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199692736.003.0004
315. Lanzaro, M. (2017). A new syndrome? The sport identification addiction and the case of Italian football ultra-fanatical support. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.508
316. Latta, F., & Cauter, E. V. (2003). Sleep and Biological Clocks. Handbook of Psychology. https://doi.org/10.1002/0471264385.wei0313
317. Lauerma, H. (2001). Klinefelter's Syndrome and sexual homicide. Journal of Forensic Psychiatry. https://doi.org/10.1080/09585180010027888
318. Lauriat, T. L., & Samson, J. (2015). Endocrine Disorders Associated with Psychological/Behavioral Problems. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199352722.013.32
319. Laynez, E. G., Bravo, B., González, S. M. B., & Portilla, N. O. (2024). The importance of including ADHD in the differential diagnosis in adults. About a case. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1707
320. Ledezma, C., Soto, K., & Suárez, M. I. (2015). Depresión en el adulto mayor en Costa Rica: un problema social. Revista Hispanoamericana de Ciencias de la Salud.
321. Leiblum, S. R., & Nathan, S. G. (2002). Persistent sexual arousal syndrome in women: A not uncommon but little recognized complaint. Sexual & Relationship Therapy. https://doi.org/10.1080/14681990220121301
322. Leitão, F., Pinho, S. A., Freitas, J., & Coutinho, F. (2024). Review of Delusional Jealousy and Its Association with Sexual Dysfunctions. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1582
323. Lemaire, J.-G. (2015). Disturbances of Identity and their Clinical Expression in Psychoanalytic Therapy with Couples. Revue de psychothérapie psychanalytique de groupe.
324. Lembo, D., Prosperi, I., & Fabrizi, A. (2009). Una nuova disfunzione sessuale femminile: Il Disturbo da Eccitazione Sessuale Persistente (PSAD). RIVISTA DI SESSUOLOGIA CLINICA. https://doi.org/10.3280/rsc2009-002003
325. Lemey, L., Mulder, L. D., Audenaert, K., Desmyter, S., & Roosens, E. (2023). Late-onset psychose: een diagnostische en therapeutische uitdaging voor de clinicus. Tijdschrift voor Geneeskunde. https://doi.org/10.47671/tvg.78.22.169
326. Levy, A. R., Crowley, T., & Gingell, C. (2000). Non‐surgical management of erectile dysfunction. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2000.00954.x
327. Lewis, F., Bogliatto, F., & Beurden, M. V. (2017). Psychosexual Aspects of Vulval Disease. https://doi.org/10.1002/9781119146087.ch24
328. León, M. S. M. D. (2017). Trastorno por déficit de atención con hiperactividad: autorregulación emocional y funciones ejecutivas.
329. Li, G., Gs, V., & IuI, P. (1988). Sexual disorders in women with slowly progressing schizophrenia. Zhurnal Nevropatologii I Psikhiatrii Imeni S S Korsakova.
330. Lin, A., Wood, S. J., & Yung, A. R. (2013). Measuring psychosocial outcome is good. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0b013e32835d82aa
331. Linzer, S., Chesir, A., Ginsburg, T., & Varas, O. (2017). Stressful Life Events. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190260859.003.0005
332. Liu, S. (2011). Relationship Discussion between Emotional Factors and Chronic Fatigue Syndrome. Liaoning Zhongyiyao Daxue xuebao.
333. Logožar, M. (2020). Depresija kao rizični čimbenik za školski uspjeh kod adolescenata.
334. Lucassen, P., Ockenburg, S. V., Gans, R. O. B., Rosmalen, J. G., & Hartman, T. O. (2022). [Fatigue].. PubMed.
335. Lucassen, P., Ockenburg, S. V., Gans, R. O. B., Rosmalen, J. G., & Hartman, T. O. (2024). [Fatigue].. PubMed.
336. Luminet, O., Taylor, G. J., Sekely, A., Ryder, A. G., Vermeulen, N., Welding, C., Porcelli, P., Schimmenti, A., Honkalampi, K., Morie, K. P., Grynberg, D., Ogrodniczuk, J. S., Goerlich, K. S., Goerlich, K. S., Kano, M., Panayiotou, G., & Pollatos, O. (2018). Alexithymia. Cambridge University Press eBooks. https://doi.org/10.1017/9781108241595
337. Luque, M. O., Barea, M. V., & Moreno, F. C. (2016). Electroconvulsive therapy (ECT) treatments in late-onset schizophrenia: Report of a case. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.2053
338. Luthra, M. (2017). Depression: Current Scenario with reference to India. Indian Journal of Community Health. https://doi.org/10.47203/ijch.2017.v29i01.001
339. Léon, P., & Staerman, F. (2012). Andropause (androgen deficiency of the aging male): diagnosis and management.. PubMed.
340. Macfarlane, S., Atee, M., Morris, T., & Cunningham, C. (2021). When responsive and reactive meet organic? Treatment implications of language use in the era of #BanBPSD. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.5545
341. Macneil, C., Hasty, M., Conus, P., Berk, M., & Scott, J. (2009). Social rhythm regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511757389.008
342. Macêdo, R. A. F. (2022). A importância da orientação vocacional/profissional para o direcionamento de carreira na adolescência. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.18
343. Madan, A., Frueh, B. C., Fowler, J. C., Stomberg, S., Bradshaw, M. R., Kelly, K. R., Weinstein, B., Luttrell, M., Danner, S. G., & Beidel, D. C. (2020). “Operator syndrome”: A unique constellation of medical and behavioral health-care needs of military special operation forces. The International Journal of Psychiatry in Medicine. https://doi.org/10.1177/0091217420906659
344. Mafi, M. (2020). 4th International Conference onPsychiatry and PsychologicalDisorders. Deleted Journal.
345. Magid, M., & Fox, I. (2021). Histrionic Personality Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197574393.003.0020
346. Maguire, G. A. (2002). Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences.. PubMed.
347. Mahon, S. M., & Carr, E. (2021). Fatigue/Lack of Endurance: Common Side Effect. Clinical journal of oncology nursing. https://doi.org/10.1188/21.cjon.s2.25
348. Mairs, H., & Bradshaw, T. (2013). Promoting mental and physical health in adults with psychosis. Nursing Standard. https://doi.org/10.7748/ns2013.07.27.47.50.e7433
349. Malik, E. M. A. E. (2000). Erectile dysfunction: An update of diagnosis and management. Qatar medical journal. https://doi.org/10.5339/qmj.2000.2.8
350. Manohar, S., Koolwal, A., & Rao, T. S. (2019). Sex and Depression. Journal of Psychosexual Health. https://doi.org/10.1177/2631831818821532
351. Manohar, S., Rao, T. S., Chandran, S., Maheshwari, S., George, M., Rao, S. S., & Sattar, F. A. (2017). Sexual Dysfunctions in Depression. Clinical Depression. https://doi.org/10.4172/2572-0791.1000125
352. Mantere, O., & Vuorilehto, M. (2015). [Recognition of mood disorders].. PubMed.
353. Marcela, P.-S. D., Herazo-Dilson, M. I., & Calvo-Gómez, J. M. (2009). DEPRESIÓN EN ANCIANOS. Revista de la Facultad de Medicina.
354. Marcus, L. C., & Plasky, P. (1988). Effects of Drugs on Psychotropic.
355. Maremmani, I., Pacini, M., & Maremmani, A. G. I. (2023). Chronic Psychosis in Dual Disorder Heroin Use Disorder Patients. https://doi.org/10.1007/978-3-031-30093-6_4
356. Mariano, E. E., Santos, A. J. C. D., Barbosa, G. H. D. S., Cardoso, É. C. J., Penha, L. F., Batista, I. P. B., Mendonça, R. F. D., Dupim, I. B. D. F., Martins, I. D. O., Morais, A. C. D. S., & Silva, A. L. P. D. (2023). DEPRESSION IN THE ELDERLY: THE INFLUENCE OF THE AGING PROCESS IN THE DEVELOPMENT OF DEPRESSION. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593552320077
357. Mario, S., & Sevilla, A. R. (2019). Estrés diario y calidad de vida en las personas con lesión medular espinal.
358. Mariola, B. (2011). Infertility as a psychological problem NiepΠodnoÊç jako problem psychologiczny.
359. Marrocco, L., Debabèche, C., & Scantamburlo, G. (2023). [How I explore … affective instability].. PubMed.
360. Martens, W. H. J. (2000). Antisocial and Psychopathic Personality Disorders: Causes, Course, and Remission—A Review Article. International Journal of Offender Therapy and Comparative Criminology. https://doi.org/10.1177/0306624x00444002
361. Martins-Monteverde, C. M. S., Padovan, T., & Juruena, M. F. (2017). Trauma and stressor-related disorders. Medicina (Ribeirão Preto). https://doi.org/10.11606/issn.2176-7262.v50isupl1.p37-50
362. Masiran, R., & Pang, N. T. P. (2017). Cognitive impairment and depressive symptoms coexisting in an elderly man. BMJ Case Reports. https://doi.org/10.1136/bcr-2016-218267
363. Mauri, M., & Ramacciotti, D. (2006). Sintomi Psichici e Somatici dei Disturbi dell'Umore: razionali di terapia. Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology.
364. McDermott, B. E. (2015). Factitious Disorder. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp234
365. McGhie-Fraser, B., Ballering, A., Lucassen, P., McLoughlin, C., Brouwers, E., Stone, J., Hartman, T. O., & Dulmen, S. V. (2024). Validation of the Persistent Somatic Symptom Stigma scale for Healthcare Professionals (PSSS-HCP). Journal of Clinical Epidemiology. https://doi.org/10.1016/j.jclinepi.2024.111505
366. McGlashan, T. H. (1992). The Positive-Negative Distinction in Schizophrenia. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1992.01820010063008
367. McKim, S., & Carson, C. C. (2011). Erectile Dysfunction: Devices. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-916-1_45
368. McLeod, T. C. V., & Register‐Mihalik, J. K. (2011). Clinical Outcomes Assessment for the Management of Sport-Related Concussion. Journal of Sport Rehabilitation. https://doi.org/10.1123/jsr.20.1.46
369. McMahon, C. (2014). Management of ejaculatory dysfunction. Internal Medicine Journal. https://doi.org/10.1111/imj.12344
370. Medina, S., & Fernando, D. (2019). Caso Christopher : El deseo, de deseo imposible en la neurosis obsesiva..
371. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
372. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). Diagnóstico y tratamiento del insomnio en el adulto mayor.
373. Menezes, M. C. D. C., Gonçalves, L. G. V., Chaves, S. C. D. S., Jaime, T. F. M., Oliveira, I. C. Z., Sobrinho, K. D. L., Oliveira, L. L. D., Araújo, J. V. L. D., Gurian, F. G., Soares, I. L. T., Nero, L. D., Pereira, P. H. D. O., Moraes, F. D. C., & Teixeira, G. P. (2023). MAIN CAUSES OF INTENTIONAL ACCIDENTS IN PEDIATRICS AND CLINICAL MANIFESTATIONS - LITERATURE REVIEW. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593712308095
374. Mesquita, M. M. M. (2008). Desejo de engravidar e doença psiquiátrica. Revista Portuguesa de Clínica Geral. https://doi.org/10.32385/rpmgf.v24i3.10506
375. Meyer, J. S., & Hamel, A. F. (2014). Models of Stress in Nonhuman Primates and Their Relevance for Human Psychopathology and Endocrine Dysfunction. ILAR Journal. https://doi.org/10.1093/ilar/ilu023
376. Michael, A., & Andrews, S. C. (2002). Paroxetine-Induced Vaginal Anaesthesia. Pharmacopsychiatry. https://doi.org/10.1055/s-2002-33196
377. Michael, A., & O’Keane, V. (2000). Sexual dysfunction in depression. Human Psychopharmacology Clinical and Experimental. https://doi.org/10.1002/1099-1077(200007)15:5<337::aid-hup207>3.0.co;2-h
378. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395
379. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395_update_001
380. Milano, W., Ambrosio, P., Carizzone, F., Biasio, V. D., Foia, M. G., Saetta, B., Milano, M. F., & Capasso, A. (2021). Menstrual Disorders Related to Eating Disorders. Endocrine Metabolic & Immune Disorders - Drug Targets. https://doi.org/10.2174/1871530321666210625145345
381. Miller, B. L., Cummings, J. L., McIntyre, H., Ebers, G. C., & Grode, M. (1986). Hypersexuality or altered sexual preference following brain injury.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.49.8.867
382. Miller, T. A. (2000). Diagnostic evaluation of erectile dysfunction.. PubMed.
383. Millner, V. S., & Ullery, E. K. (2002). A Holistic Treatment Approach to Male Erectile Disorder. The Family Journal. https://doi.org/10.1177/106648002236768
384. Milosavljević, M., & Vuković, O. (2020). Mental disorders in the peripartum period. Psihijatrija danas. https://doi.org/10.5937/psihdan2001131m
385. Mina, S. (2019). Compulsive sexual behavior in depressed women. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_137_18
386. Miner, M., & Hellstrom, W. J. (2008). Distinguishing Premature Ejaculation from Other Sexual Function Disorders. Postgraduate Medicine. https://doi.org/10.3810/pgm.2008.04.1761
387. Mitchell, J. C., & Popkin, M. K. (1982). Antipsychotic drug therapy and sexual dysfunction in men. American Journal of Psychiatry. https://doi.org/10.1176/ajp.139.5.633
388. Mitchell, P. B., Goodwin, G. M., Johnson, G. F., & Hirschfeld, R. M. A. (2008). Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disorders. https://doi.org/10.1111/j.1399-5618.2007.00559.x
389. Mittal, R., Rijal, R., Sharma, B., & Gupta, A. K. (2024). Late Onset Psychosis with Affective Symptoms: Clinical Nuances or a Diagnostic Conundrum?. Med Phoenix. https://doi.org/10.3126/medphoenix.v9i1.67243
390. Mkize, D. L. (2003). Evidence-based interventions for dementia in general practice : main topic. CME: Your SA Journal of CPD.
391. Mola, J. R. (2015). Erectile Dysfunction in the Older Adult Male. Urologic Nursing. https://doi.org/10.7257/1053-816x.2015.35.2.87
392. Moline, M., & Zendell, S. M. (2000). Evaluating and managing premenstrual syndrome.. PubMed.
393. Mollah, A. S., & Khan, M. I. H. (2013). Erectile Dysfunction and Its Management: An Update. Journal of Chittagong Medical College Teachers Association. https://doi.org/10.3329/jcmcta.v23i2.56831
394. Monteiro, M. C. J., & Reis-Pina, P. (2013). Chronic Pain - Perceptions, Limitations and Implications. A Social Perspective. Biomedical and Biopharmaceutical Research. https://doi.org/10.19277/bbr.10.1.47
395. Montejo, Á. L. (2020). Novel Research in Sexuality and Mental Health. MDPI eBooks. https://doi.org/10.3390/books978-3-03943-357-5
396. Montejo, Á. L., Montejo, L., & Baldwin, D. S. (2018). The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management. World Psychiatry. https://doi.org/10.1002/wps.20509
397. Montejo, Á. L., Montejo, L., & Navarro-Cremades, F. (2015). Sexual side-effects of antidepressant and antipsychotic drugs. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0000000000000198
398. Montgomery, K. A. (2008). Sexual desire disorders.. PubMed.
399. Montoya, A., & Alejandra, M. (2020). Estrés laboral y sus consecuencias en la salud que afectan el rendimiento.
400. Mooradian, A. D., & Korenman, S. G. (2006). Management of the Cardinal Features of Andropause. American Journal of Therapeutics. https://doi.org/10.1097/01.mjt.0000132252.80403.c9
401. Moorthi, K., Pertin, S., & Radhika, P. (2023). Homoeopathy for obsessive-compulsive disorder: A case report. Indian Journal of Research in Homoeopathy. https://doi.org/10.53945/2320-7094.1117
402. Morel-Portelette, M. (2020). Anorexie mentale masculine : revue de la littérature.
403. Morrell, M. J. (1991). Sexual Dysfunction in Epilepsy. Epilepsia. https://doi.org/10.1111/j.1528-1157.1991.tb05891.x
404. Mucci, A., Bucci, P., Giordano, G. M., Brando, F., & Galderisi, S. (2021). Apathy in schizophrenia: assessment in clinical settings and overlap with other dimensions of impairment. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.159
405. Mulligan, T., & Katz, P. G. (1988). Erectile Failure in the Aged: Evaluation and Treatment. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.1988.tb03434.x
406. Murray, R. B. (1996). Stressors and Coping Strategies of Homeless Men. Journal of Psychosocial Nursing and Mental Health Services. https://doi.org/10.3928/0279-3695-19960801-13
407. Muskin, P. R., & Mirasol, E. G. (2008). Physical Signs and Symptoms. Psychiatry. https://doi.org/10.1002/9780470515167.ch37
408. Mut, E. A., Pălădoiu, C., & Stănescu, M. (2021). Somatoform and conversion disorders as psychological defences. Journal of Educational Sciences & Psychology. https://doi.org/10.51865/jesp.2021.1.19
409. Muñoz-Lara, J. (2015). Depresión en la persona adulta mayor institucionalizada: Un nuevo reto. Revista Hispanoamericana de Ciencias de la Salud (RHCS).
410. Münster, T., & Tzabazis, A. (2013). Somatische Intervention und Demenz - Einfluss von Chirurgie und Anästhesie auf kognitive Funktionen. PSYCH up2date. https://doi.org/10.1055/s-0033-1343131
411. Narang, T., Garima, & Singh, S. M. (2016). Psychosexual disorders and dermatologists. Indian Dermatology Online Journal. https://doi.org/10.4103/2229-5178.182349
412. Narayan, J. P., Verma, D., & Islam, R. (2022). Chronic Mania-A Case Report. International Journal of Psychiatric Nursing. https://doi.org/10.37506/ijpn.v9i1.18831
413. Nicol, A., & Chung, E. (2023). Male sexual dysfunction: Clinical diagnosis and management strategies for common sexual problems. Australian Journal of General Practice. https://doi.org/10.31128/ajgp-09-22-6559
414. Nosek, M. A., & Howland, C. A. (1998). Abuse and Women with Disabilities.
415. Nunes, M. L., & Bruni, O. (2015). Insomnia in childhood and adolescence: clinical aspects, diagnosis, and therapeutic approach. Jornal de Pediatria. https://doi.org/10.1016/j.jped.2015.08.006
416. Nusbaum, M. (2002). Erectile dysfunction: prevalence, etiology, and major risk factors.. PubMed.
417. Ochoa, A., Corgo, S. R., Pey, M. A., Cristobal, M., Vicente, E. P., Campos, A., Gordillo, C., Ibañez, A. C. C., Astorga, A. Á., & Huelva, P. A. (2023). Chronic disease (CD) during transition from child to adult.Psychopathological consequences and coping strategies. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.1565
418. OIu, S., & Mv, R. (2008). [Social-psychological problems and their solution in anesthesiologists-resuscitators with different length of professional work]..
419. Okada, H., Shin, T., & Kobori, Y. (2016). [Early-onset and late-onset male hypogonadotropic hypogonadism and osteoporosis].. PubMed.
420. Okechukwu, C. E. (2021). Neuropsychopathology of gambling disorder. MGM Journal of Medical Sciences. https://doi.org/10.4103/mgmj.mgmj_32_21
421. Okolie, K., Perampalam, S., Barker, A. T., & Nolan, C. J. (2017). A case of Klinefelter syndrome with hypersexual desire. Endocrinology Diabetes and Metabolism Case Reports. https://doi.org/10.1530/edm-17-0082
422. Okonoda, K. M., & Allagoa, E. L. P. (2020). Compulsive Sexual Behaviors in a Young Male with Social Anxiety Disorder (Social Phobia). Journal of psychiatry.
423. Oliveira, S., Canha, J., & Pereira, S. P. (2013). 2362 – Is it a prodrome of psychosis? Or is it naanxious disorder? A case report. European Psychiatry. https://doi.org/10.1016/s0924-9338(13)77202-x
424. Olmedo, A., & Rolando, M. (2015). Informe psicológico pericial: situación de violencia intrafamiliar, “maltrato física, psicológica y sexual”, grado de afectación psicológico..
425. Onipko, Z. (2020). Phenomenon of Procrastination in Modern Psychology: Theoretical Fundamentals of the Research. Bulletin of Taras Shevchenko National University of Kyiv Series “Psychology”. https://doi.org/10.17721/bsp.2020.2(12).12
426. Orengo, C. A., Fullerton, G., & Tan, R. S. (2004). Male depression: a review of gender concerns and testosterone therapy.. PubMed.
427. Ortiz, S. R., Carrillo-Albornoz, E. J. O., & Coque, J. A. R. (2016). La intervención policial con sujetos confuso-agitados: El denominado “delirio agitado”. Cuadernos de la Guardia Civil: Revista de seguridad pública.
428. OSPINA, C. B. (2021). Estrés, Ansiedad e Insomnio: Asociación de enemigos ocultos que destruyen nuestro equilibrio mental. Reporte de caso.. https://doi.org/10.31219/osf.io/s7m3k
429. Ostrowski, M., & Mietkiewicz, M. (2015). Approach of the sexuality of Alzheimer's disease patients according to caregivers’ guides approach. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2015.0580
430. Oviedo, H. E. C., Andrade, B. A., Nogales, J. R. D., & Apaza, G. S. (2015). SÍNDROME DE CUTTING (AUTOLESIONISMO). Revista de Investigación e Información en Salud. https://doi.org/10.52428/20756208.v10i25.542
431. Padmos, R. C. (2009). Inflammatory Monocytes in Bipolar Disorder and Related Endocrine Autoimmune Diseases.
432. Page, C. E., Soreth, B., Metcalf, C. A., Johnson, R. L., Duffy, K. A., Sammel, M. D., Loughead, J., & Epperson, C. N. (2024). Natural vs. Surgical Postmenopause and Psychological Symptoms Confound the Effect of Menopause on Executive Functioning Domains of Cognitive Experience. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/appi.focus.23021034
433. Paidi, G., Jean, M., Oduwole, A., Gautam, N., Kapoor, K., & Paidi, R. (2022). Chronic Unexplained Vomiting: A Case Report on Psychogenic Vomiting. Cureus. https://doi.org/10.7759/cureus.25959
434. Palmer, B. A. (2015). Personality and Illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214883.003.0041
435. Palmer, B. A. (2021). Personality and Illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0042
436. Palmer, S. C., Vecchio, M., Tonelli, M., Johnson, D. W., & Strippoli, G. F. (2012). Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfs135
437. Pamukuntla, M., Viriti, U., Penjuri, S. C. B., & Anusha, M. S. (2018). CASE REPORT OF DHAT SYNDROME INDUCED PSYCHOSIS: A SEMEN LOSS SYNDROME RELATED TO PSYCHOLOGICAL DISTRESS. International Research Journal of Pharmacy. https://doi.org/10.7897/2230-8407.09461
438. Pantoularis, I., Garyfallos, G., Lobtzianidou, M., Livanos, A., Dasoukis, I., & Adamopoulou, A. (2008). Axis I-Axis II comorbidity of borderline personality disorder: gender-related differences. Annals of General Psychiatry. https://doi.org/10.1186/1744-859x-7-s1-s226
439. Paredes, D. F. D., Farfán, J. C. P., Orellana, J. M. F., & Legarda, A. A. B. (2019). Trastorno disfórico premenstrual. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.199-217
440. Pargeon, K., Anderson, K. E., & Weiner, W. J. (2011). Sexual Dysfunction. Parkinson s Disease. https://doi.org/10.1002/9781444397970.ch27
441. Pasupuleti, S., & Rayachoti, B. S. (2021). Obsessive Jealousy Masquerading as Delusional Disorder. Indian Journal of Private Psychiatry. https://doi.org/10.5005/jp-journals-10067-0088
442. patil, A. J. (2017). Role of satvavajaya chikitsa in jara with special reference to socio-psychological problems. Journal of Ayurveda and Holistic Medicine.
443. Payne, R., & Sadovsky, R. (2007). Identifying and treating premature ejaculation: importance of the sexual history.. Cleveland Clinic Journal of Medicine. https://doi.org/10.3949/ccjm.74.suppl_3.s47
444. Pedroso, A. P. F., Tomasetti, C. S., Coelho, C. I., Pinho, E. C. D. A., & Oliani, S. M. (2018). Stress em renais crônicos: treino de relaxamento amenizando a sessão de hemodiálise. Revista Terra & Cultura: Cadernos de Ensino e Pesquisa.
445. Penlington, C., Urbanek, M., & Barker, S. (2018). Psychological Theories of Pain. Primary Dental Journal. https://doi.org/10.1177/205016841800700407
446. Perkinson, R. R., & Jongsma, A. E. (1997). The Chemical Dependence Treatment Planner.
447. Pesce, V., Seidman, S. N., & Roose, S. P. (2002). Depression, antidepressants and sexual functioning in men. Sexual & Relationship Therapy. https://doi.org/10.1080/14681990220149086
448. Petrie, W. M. (2015). Sexual Effects of Antidepressants and Psychomotor Stimulant Drugs. Modern problems of pharmacopsychiatry/Modern trends in pharmacopsychiatry. https://doi.org/10.1159/000402337
449. Pettigrew, J., & Novick, A. M. (2021). Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment. Journal of Midwifery & Women s Health. https://doi.org/10.1111/jmwh.13283
450. Peveler, R. (2002). ABC of psychological medicine: Depression in medical patients. BMJ. https://doi.org/10.1136/bmj.325.7356.149
451. Peña, D. A., Pérez, M. L., & Pinzón, L. F. C. (2014). Línea de investigación psicología clínica y de la salud..
452. Phillips, R. L., & Slaughter, J. C. (2000). Depression and sexual desire.. PubMed.
453. Piggott, T. A., Duran, A. N., Jalnapurkar, I., Kimm, T., Linscheid, S., & Allen, M. (2019). Sex Differences in Anxiety Disorders. https://doi.org/10.1093/oxfordhb/9780190649739.013.21
454. Pilling, S., Baron‐Cohen, S., Megnin‐Viggars, O., Lee, R., & Taylor, C. V. (2012). Recognition, referral, diagnosis, and management of adults with autism: summary of NICE guidance. BMJ. https://doi.org/10.1136/bmj.e4082
455. Pirke, K., Fichter, M., Schweiger, U., Krieg, C., Ploog, D., & Remschmidt, H. (2000). Langversion der Behandlungsleitlinie Eßstörungen. Steinkopff eBooks. https://doi.org/10.1007/978-3-642-57730-7_1
456. Pityk, O., Pityk, M., & Kuzhda, I. (2016). Social-stress Disorder. What Does it Mean for the people?. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.1646
457. Pivonello, R., Neggers, S. J. C. M. M., & Imran, S. A. (2023). Psychopathology in Acromegaly—Real and Perceived. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad237
458. Piwuna, C. G., Makput, D. M., & Wakil, M. A. (2015). Persistent delusional disorder in a 32 year old male. Highland Medical Research Journal.
459. Pollack, M. H. (2001). Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder.. PubMed.
460. Pontari, M. A. (2020). Definition and epidemiology of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). https://doi.org/10.5680/lhuii000050
461. Pope, H. G., McElroy, S. L., Keck, P. E., Hudson, J. I., Faedda, G. L., & Swann, A. C. (1992). Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. American Journal of Psychiatry. https://doi.org/10.1176/ajp.149.12.1633
462. Prabha, Y. S. (2023). Stress as a Topic of Concern in Gut Health: A Review. UTTAR PRADESH JOURNAL OF ZOOLOGY. https://doi.org/10.56557/upjoz/2023/v44i123527
463. Prasetya, E. C., Subagyo, R., Mahyuddin, M. H., Haniifah, U., Rafida, M., Hamida, A., Ramzy, M., & Prasetya, M. T. (2022). Continuously Paranoid Schizophrenia in Young Man: A Case Report. Asian Australasian Neuro and Health Science Journal (AANHS-J). https://doi.org/10.32734/aanhsj.v4i2.9165
464. Prater, C., & Zylstra, R. G. (2002). Autism: a medical primer.. PubMed.
465. Praško, J., Herman, E., Raszka, M., Hovorka, J., & Doubek, P. (2007). Disociativní poruchy a jejich léčba. Medicína pro praxi.
466. Previnaire, J.-G., Lecourt, G., Soler, J.-M., & Denys, P. (2014). Sexual disorders in men with multiple sclerosis: Evaluation and management. Annals of Physical and Rehabilitation Medicine. https://doi.org/10.1016/j.rehab.2014.05.002
467. Priya, A., Chaturvedi, S., Bhasin, S., Bhatia, M., & Radhakrishnan, G. (2018). Depression, anxiety and stress among pregnant women: A community-based study. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_230_17
468. Pruszyński, J. (2015). Non-cognitive symptoms of dementia. Postępy Nauk Medycznych.
469. Quadri, R., & Fonzo, D. (1993). [Libido-related changes in the elderly].. PubMed.
470. Qureshi, M. A., & Wasti, S. A. (2014). Lay-off Survivor Sickness Syndrome (Investigating the Lasting Impact on Performance of Survivors in the Context of Age and Gender in Private Sector Organizations of Pakistan). International Journal of Human Resource Studies. https://doi.org/10.5296/ijhrs.v4i3.6078
471. Radmanović, M. B., & Burgić, S.-S. (2020). Comorbidity in Children and Adolescents with ADHD. IntechOpen eBooks. https://doi.org/10.5772/intechopen.94527
472. Radulović, N., Mišković, M., Zoric, D., Maglov, T., & Ilić, D. (2008). Crisis intervention. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2008.01.569
473. Ramos, I. M., Ferraz, I., Coelho, T., & Mota, M. (2015). First Faster Then Slower. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)32100-3
474. Rana, N., Drake, M. J., Rinko, R., Dawson, M., & Whitmore, K. (2018). The fundamentals of chronic pelvic pain assessment, based on international continence society recommendations. Neurourology and Urodynamics. https://doi.org/10.1002/nau.23776
475. Rao, T. S., & Kumar, M. A. (2008). Agenda for specialty section in addiction medicine. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.44741
476. Rao, T. S., George, M., Maheshwari, S., Chandran, S., Rao, S., & Manohar, S. (2018). Psychosocial intervention for sexual addiction. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_38_18
477. Rao, T. S., Maheshwari, S., George, M., Chandran, S., Manohar, S., & Rao, S. S. (2018). Psychosocial interventions for sexual dysfunction in addictive disorders. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_37_18
478. Rayfield, A., Thomas, C., & Borovicka, M. C. (2014). Management of behavioral and psychological symptoms of dementia: The role of mood stabilizers. Mental Health Clinician. https://doi.org/10.9740/mhc.n204493
479. Razafsha, M., Buch, K., Vitolo, O. V., & Chemali, Z. (2020). When real life conditions do not follow textbook diagnosis: A diagnostic challenge from a neuropsychiatric clinic. The International Journal of Psychiatry in Medicine. https://doi.org/10.1177/0091217420979629
480. Razdan, S., Greer, A., Patel, A. S., Alameddine, M., Jue, J. S., & Ramasamy, R. (2017). Effect of prescription medications on erectile dysfunction. Postgraduate Medical Journal. https://doi.org/10.1136/postgradmedj-2017-135233
481. Rd, G. (1996). Behavioral factors in the management of back pain.. PubMed.
482. Reid, W. H., Balis, G. U., & Sutton, B. (1997). The treatment of psychiatric disorders : revised for DSM-IV.
483. Reiss, S. (2008). Overcoming Personal Troubles. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139167451.006
484. Reynaert, C., Zdanowicz, N., Janne, P., & Jacques, D. (2010). Depression and sexuality.. PubMed.
485. Reynolds, R. D. (1997). More names for depression: is a rose a rose?. JAMA. https://doi.org/10.1001/jama.278.12.982
486. Rizwana, S. R. S., Josna, T. J. T., & G.V.Nagaraju, G. (2019). CASE STUDY ON DEPRESSION. International Journal of Indigenous Herbs and Drugs.
487. Rochira, V., Carani, C., & Granata, A. R. M. (2022). Management of Sexual Dysfunction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198870197.003.0193
488. Rodas, P. A. V., & Pena, M. (2024). Prevalência da alteração de capacidade funcional, síndrome de fragilidade e sarcopenia em pacientes com mais de 60 anos atendidos na Associação Fluminense de Reabilitação. Acta Fisiátrica. https://doi.org/10.11606/issn.2317-0190.v31isupl.1a225105
489. Rodríguez, E. O., Esquivel, P. S., & Triana, I. M. (2024). Un panorama actualizado de la dispepsia. Revista médica de Panamá. https://doi.org/10.37980/im.journal.rmdp.20242296
490. Rodríguez, L., & Pilar, M. D. (2014). Consecuencias físicas y psicológicas del abuso sexual infantil.
491. Rodríguez, S. P. G., & Maestre, M. Á. M. (2006). Menopausia y trastornos psicoafectivos. Ginecología y obstetricia clínica/Ginecología y obstetricia clínica.
492. Rollini, M., & Baud, P. (2008). [Pharmacological treatment of attention-deficit/hyperactivity disorder in adults].. PubMed.
493. Romão, A. P. M. S., Gorayeb, R., Romão, G. S., Poli‐Neto, O. B., Reis, F. J. C. D., Silva, J. C. R. E., Barbosa, H. D. F., & Nogueira, A. A. (2010). Chronic pelvic pain: multifactorial influences. Journal of Evaluation in Clinical Practice. https://doi.org/10.1111/j.1365-2753.2010.01485.x
494. Ronad, S. V., Patail, C. S., Gondbal, S. H., TC, K., Ronad, M., Pankaja, T., Badesgol, R., & Singhal, P. K. J. (2019). Professionals in metro cities suffer from anxiety disorder. Nursing & Care Open Access Journal. https://doi.org/10.15406/ncoaj.2019.06.00198
495. Roohafza, H. (2010). STRESS AND HEART. ARYA atherosclerosis.
496. Rosen, R. C., & Nelson, C. J. (2011). Validated Questionnaires in Male Sexual Function Assessment. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-916-1_22
497. Rosen, R. C., Lane, R., & Menza, M. (1999). Effects of SSRIs on Sexual Function. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199902000-00013
498. Rosso, M. D., & Gaglio, P. (2008). Síndrome de fatiga crónica. Evidencia actualizacion en la práctica ambulatoria. https://doi.org/10.51987/evidencia.v11i1.5946
499. Rosyanti, L., Hadi, I., Antari, I., & Ramlah, S. (2023). Faktor Penyebab Gangguan Psikologis pada Penderita Penyakit Ginjal Kronis yang menjalani Hemodialisis: Literatur Reviu Naratif. Health Information Jurnal Penelitian. https://doi.org/10.36990/hijp.v15i2.1102
500. Rothenberger, A., & Hüther, G. (1997). [The role of psychosocial stress in childhood for structural and functional brain development:neurobiological basis of developmental psychopathology].. PubMed.
501. Rottnek, F., Searight, H. R., & Abby, S. L. (2001). Conduct disorder: diagnosis and treatment in primary care.. PubMed.
502. Roy, A. (1996). Aetiology of Secondary Depression in Male Alcoholics. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.169.6.753
503. Roy, B. A. (2015). Overreaching/Overtraining. ACSMʼs Health & Fitness Journal. https://doi.org/10.1249/fit.0000000000000100
504. Rozanova, I. K., Petrovskaia, M. V., & Martynova, M. V. (2007). [Examination of personality and emotional-volitional disorders in the homeless with tuberculosis]..
505. Rozenberg, S. (2008). [Chronic low back pain: definition and treatment].. PubMed.
506. Räsänen, S., Hakko, H., Herva, A., Isohanni, M., Nieminen, P., & Moring, J. (1999). Gender Differences in Long-Stay Psychiatric Inpatients. International Journal of Mental Health. https://doi.org/10.1080/00207411.1999.11449447
507. Ríos, C. G., Sánchez, M. V., Campos, M. L. P., Lozano, C. F., & Montañés, P. M. (2021). Mitos y realidades sobre la enuresis en pediatría.. Revista Sanitaria de Investigación.
508. Sahakian, B. J., & Morein‐Zamir, S. (2011). Depression and resilience: insights from cognitive, neuroimaging, and psychopharmacological studies. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199600434.003.0023
509. Saint‐Jean, O., Antoine, Edy, Souid, M., & Barthélémy, F. (2004). [Concerning: aging, the beginning of dialysis, the beginning of dependence: repercussions on the psychopathology of the very old dialysis patient].. PubMed.
510. Salavera, C. (2011). Motivo de abandono de proceso en personas sin hogar: trastornos de personalidad vs problemas psicosociales. Documentos de trabajo social: Revista de trabajo y acción social.
511. Samico, A., & Miguel, A. S. (2019). RUDE AND AGRESSIVE COMMUNICATION BETWEEN PHYSICIANS: HOW DOES IT AFFECT US?. https://doi.org/10.26226/morressier.5d1a038257558b317a140bf9
512. Samuel, D. B., & Griffin, S. A. (2015). Obsessive–Compulsive Personality Disorder. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp210
513. Sansone, R. A., Sansone, L. A., & Righter, E. L. (1998). Panic Disorder: The Ultimate Anxiety. Journal of women's health. https://doi.org/10.1089/jwh.1998.7.983
514. Santini, I., Lauretis, D., Roncone, R., Tosone, A., Bianchini, D’Onofrio, S., Ortenzi, R., Giusti, L., Casacchia, M., & Pollice, R. (2014). [Psychotropic-associated sexual dysfunctions: a survey of clinical pharmacology and medication-associated practice].. PubMed. https://doi.org/10.7417/ct.2014.1728
515. Santos-Cubiñá, J., Castaing-Lespier, P. A., Sabaté, N., Torres-Martin, A., & Quiñones-Fernandini, V. M. (2013). Menstrual psychosis: presenting symptom of bipolar disorder not otherwise specified in a 13-years-old Hispanic female.. PubMed.
516. Santoso, B. (2024). From bullying to suicide: the pathways road in adolescent. Surabaya Medical Journal. https://doi.org/10.59747/smjidisurabaya.v2i2.89
517. Santucci, K. T. T., Miranda, A. H., Oliveira, A. J. R., & Vieira, A. F. D. B. (2022). Psicologia organizacional e do trabalho e a humanização no contexto hospitalar. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.15
518. Sardesai, A., Muneshwar, K. N., Bhardwaj, M., & Goel, D. B. (2023). The Importance of Early Diagnosis of Somatic Symptom Disorder: A Case Report. Cureus. https://doi.org/10.7759/cureus.44554
519. Sari, M. N., Sulyaman, S., Sulistiono, A., & Ramadhian, M. R. (2016). Gangguan Kepribadian dan Perilaku Akibat Penyakit, Kerusakan, dan Disfungsi Otak pada Pria Usia 45 Tahun. Jurnal Medula.
520. Sarkar, S. (2016). Psychiatric Polypharmacy, Etiology and Potential Consequences. Current Psychopharmacologye. https://doi.org/10.2174/2211556005666160916124719
521. Sarkar, S., & Dinesh, M. (2023). The threshold problem of impairment criteria in psychiatric diagnosis. Journal of SAARC Psychiatric Federation. https://doi.org/10.4103/jspf.jspf_12_23
522. Sarkar, S., Singh, S. M., Balachander, S., & Rao, P. (2014). Chronic fatigue syndrome: A review. Medical Journal of Dr D Y Patil University. https://doi.org/10.4103/0975-2870.135252
523. Sass, L. A. (2003). “Negative Symptoms,” Commonsense, and Cultural Disembedding in the Modern Age. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511616297.015
524. Satpathy, S. V. (2016). Flibanserin- A Novel drug for Hypoactive Sexual Desire Disorder. International Archives of BioMedical and Clinical Research. https://doi.org/10.21276/iabcr.2016.2.1.3
525. Scavello, I., Maseroli, E., Stasi, V. D., & Vignozzi, L. (2019). Sexual Health in Menopause. Medicina. https://doi.org/10.3390/medicina55090559
526. Scheiber-Nogueira, M.-C. (2009). Troubles sexuels et syndrome de la queue-de-cheval Sexual dysfunction in cauda equina syndrome.
527. Scherbaum, N., & Specka, M. (2014). Komorbide psychische Störungen bei Opiatabhängigen. Suchttherapie. https://doi.org/10.1055/s-0033-1363240
528. Schildkrout, B. (2011). Characteristics That Make Somatic Diseases Difficult to Detect. https://doi.org/10.1002/9781118083598.ch3
529. Schildkrout, B. (2011). Specific Mental Signs and Symptoms. https://doi.org/10.1002/9781118083598.ch9
530. Schildkrout, B. (2014). Delirium. https://doi.org/10.1002/9781394260447.ch2
531. Schildkrout, B. (2014). Disease #53: Postconcussion Syndrome. https://doi.org/10.1002/9781394260447.ch81
532. Schildkrout, B. (2014). Disease #54: Premenstrual Dysphoric Disorder and Premenstrual Syndrome. https://doi.org/10.1002/9781394260447.ch82
533. Schildkrout, B. (2014). Vegetative Symptoms. https://doi.org/10.1002/9781394260447.ch23
534. Schneider, J. P., & Irons, R. R. (1996). Differential diagnosis of addictive sexual disorders using the dsm-iv. Sexual Health & Compulsivity. https://doi.org/10.1080/10720169608400096
535. Schneiderman, N., Ironson, G., & Siegel, S. D. (2004). Stress and Health: Psychological, Behavioral, and Biological Determinants. Annual Review of Clinical Psychology. https://doi.org/10.1146/annurev.clinpsy.1.102803.144141
536. Schredl, M., Schramm, F., Valli, K., Mueller, E. M., & Sandman, N. (2020). Nightmare Distress Questionnaire: associated factors. Journal of Clinical Sleep Medicine. https://doi.org/10.5664/jcsm.8824
537. Schweitzer, J. B. (2010). Attention‐Deficit/Hyperactivity Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0096
538. Segal, D. L., Qualls, S. H., & Smyer, M. A. (2017). Sexual Disorders, Sleep Disorders, and Chronic Pain. https://doi.org/10.1002/9781119133186.ch12
539. Segraves, R. (2008). Management of Hypoactive Sexual Desire Disorder. KARGER eBooks. https://doi.org/10.1159/000126622
540. Seidman, S. N. (2002). Exploring the relationship between depression and erectile dysfunction in aging men.. PubMed.
541. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
542. Sengupta, S. S., & Tasneem, H. (2023). Male sexual dysfunction: Hahnemann’s obvious cause of the modern generation. International Journal of Homoeopathic Sciences. https://doi.org/10.33545/26164485.2023.v7.i4a.956
543. Setiawan, I. M. A. (2015). GANGGUAN HIPOKONDRIK: SEBUAH LAPORAN KASUS. DOAJ (DOAJ: Directory of Open Access Journals).
544. Sh.H., S., L.A., T., N.I., K., V.K., A., & Nurkhodjaev, S. (2020). Diagnostics of Dysthymic Disorders and Therapy of Patients with Opium Addiction with AnxietyDepressive Variant of Post-Withdrawal Syndrome. International Journal of Current Research and Review. https://doi.org/10.31782/ijcrr.2020.122320
545. Shakhar, K., & Fleisig, D. (2013). How to Cope with Stress and Depression in Women with Recurrent Miscarriage. https://doi.org/10.1002/9781118749012.ch13
546. Shankar, B. S., Yadukul, S., & Shivakumar, B. (2014). A Case of Genital Self-mutilation Committed Before Suicide. Egyptian Journal of Forensic Sciences. https://doi.org/10.1016/j.ejfs.2014.07.004
547. Shanmugaratnam, S., Shanmugaratnam, H., & Parisaei, M. M. (2013). Premenstrual syndrome. InnovAiT Education and inspiration for general practice. https://doi.org/10.1177/1755738012467442
548. Sharma, A. (2019). Erectile Dysfunction: The Male Stigma. International Journal of Surgery and Medicine. https://doi.org/10.5455/ijsm.erectile-dysfunction
549. Sharp, L. K., & Lipsky, M. S. (2002). Screening for depression across the lifespan: a review of measures for use in primary care settings.. PubMed.
550. Sharpe, M., & Wilks, D. (2002). ABC of psychological medicine: Fatigue. BMJ. https://doi.org/10.1136/bmj.325.7362.480
551. Sheykhi, M. T. (2020). Inevitable aging and the resultant mental disorders In developing countries: a sociological appraisal. Clinical Research and Clinical Trials. https://doi.org/10.31579/2693-4779/002
552. Shin, J. E., Park, K. S., & Nam, K. (2019). Chronic Functional Constipation. Korean Journal of Gastroenterology. https://doi.org/10.4166/kjg.2019.73.2.92
553. Shishkova, V. N. (2023). Psycho-emotional state of patients with chronic non-communicable diseases: important aspects of therapy. Meditsinskiy sovet = Medical Council. https://doi.org/10.21518/ms2023-230
554. Shkembi, A., Skenderi, E., Imeraj, F., Kuneshka, N., Xhelili, G., & Durma, A. (2023). A case of sexual abuse and art therapy. World Journal of Advanced Research and Reviews. https://doi.org/10.30574/wjarr.2023.18.1.0566
555. Shoenfeld, H. (1999). [When are menopausal symptoms psychiatric?].. PubMed.
556. Silva, E. P. D., Maso, A. D. S., Moura, S. G. F., Andrade, T. T. D., Oliveira, V. D. L., Oliveira, R. B., Andrade, T. T. D., Lídio, M. D. S., Jales, W. K. B., & Araújo, L. F. D. (2022). Violência obstétrica: uma análise de conceito. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.4
557. Silva, L. I. F. D., Souza, L. M., Gonzales, M. F., & Jurado, S. R. (2015). SLEEP DISORDERS IN CHILDHOOD. Simpósio Internacional de Neurociências da Grande Dourados.
558. Silva, L. M. D., Raposo-Lima, C., Soares, C. M. G., Cerqueira, J., & Morgado, P. (2016). Koro Syndrome in an Obsessive-Compulsive Disorder Patient. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.1825
559. Silva, L. M. R. (2015). A Demência Frontal: ou o Risco da Perda do Eu e do Outro. Psicologado.
560. Silveira, L. F. G., & Latrônico, A. C. (2013). Approach to the Patient With Hypogonadotropic Hypogonadism. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2012-3550
561. Simonsen, E., Meisner, M. W., Bach, B., & Kongerslev, M. (2018). [Diagnostic and treatment of personality disorders].. Research Portal Denmark.
562. Singh, N. R., & Sandhu, I. M. S. (2019). Absence of Nocturnal Penile Tumescence: An Earlier Sign of Erectile Dysfunction and Its Linked Comorbid Conditions. AMEI s Current Trends in Diagnosis & Treatment. https://doi.org/10.5005/jp-journals-10055-0074
563. Siraj, Q. H. (1998). Impotence. Clinical Nuclear Medicine. https://doi.org/10.1007/978-1-4899-3356-0_34
564. Sloan, R. (2022). Obsessive-compulsive disorder and related disorders. InnovAiT Education and inspiration for general practice. https://doi.org/10.1177/17557380221112682
565. Smith, P. J., & Blumenthal, J. A. (2015). Exercise and Physical Activity in the Prevention and Treatment of Depression. Routledge eBooks. https://doi.org/10.4324/9780203132678.ch8
566. Smith, S. S. (2019). Insomnia and Clinical Sleep Disturbance in Later Life. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.419
567. Snyder, S. L., Byne, W., & Lozyniak, S. (2016). Sexual Dysfunctions, Gender Dysphoria, and Paraphilic Disorders. https://doi.org/10.1002/9781118654231.ch21
568. Solanki, O., & Khatri, R. (2022). EVALUATION OF PSYCHOSEXUAL DYSFUNCTIONS ON INDIVIDUALS (MALE) CONSUMING ALCOHOL. PARIPEX-INDIAN JOURNAL OF RESEARCH. https://doi.org/10.36106/paripex/1707130
569. Solís, J. C. (2013). Diagnostico y tratamiento del síndrome premenstrual. Revista Médica de Costa Rica y Centroamérica.
570. Sonavane, S., Motwani, S., Karia, S., Desousa, A., & Hukumchand, A. (2023). Sexual Dysfunction with Antidepressants: A Clinical Review. Indian Journal of Private Psychiatry. https://doi.org/10.5005/jp-journals-10067-0143
571. Sousa, A. D., & Lodha, P. (2019). Sexual issues in dementia: An overview. Telangana Journal of Psychiatry. https://doi.org/10.18231/j.tjp.2019.003
572. Sousa, R. R., Silva, M. A. D., Assunção, L. A. D., Santos, V. V. B., & Guimarães, S. S. S. (2022). Exames radiológicos para diagnostico de COVID-19. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.20
573. Souza, S. D. (2019). SP0208 UNDERSTANDING THE IMPACT OF PAIN, SLEEP AND FATIGUE ON PATIENTS LIVES. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2019-eular.8456
574. Spajić, M. (2015). Zdravstvena njega prisilno hospitaliziranih psihijatrijskih bolesnika.
575. Spoelstra, S. K., Waldinger, M. D., Nijhuis, E. R., & Schultz, W. C. M. W. (2013). [A woman with restless genital syndrome: a difficult-to-treat condition].. PubMed.
576. Stafie, C. S., & Stafie, I. I. (2019). POST COITAL ALLERGY – A CASE REPORT OF POST ORGASMIC ILLNESS SYNDROME. The Medical-Surgical Journal.
577. Stahl, S. M. (2000). "Dr. Stahl Replies". The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v61n0610c
578. Steffens, D. C., Blazer, D. G., & Beyer, J. L. (2013). Mood Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt05
579. Steineck, G., Bergmark, K., Henningsohn, L., al‐Abany, M., Dickman, P. W., & Helgason, Á. R. (2002). Symptom Documentation in Cancer Survivors as a Basis for Therapy Modifications. Acta Oncologica. https://doi.org/10.1080/02841860260088782
580. Steinert, C., Heim, N., & Leichsenring, F. (2021). Procrastination, Perfectionism, and Other Work-Related Mental Problems: Prevalence, Types, Assessment, and Treatment—A Scoping Review. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2021.736776
581. Stephen, S., & Bailey, C. (2013). Managing disruptive behaviour disorders in children.. PubMed.
582. Stewart, S. M. (2013). Depression. The Encyclopedia of Cross‐Cultural Psychology. https://doi.org/10.1002/9781118339893.wbeccp158
583. Stojaković, M., & Stojakovic, B. (2017). FORENZIČKO PSIHIJATRIJSKI ASPEKTI VJEŠTAČENJA BOLESTI ZAVISNOSTI. Psymedica. https://doi.org/10.7251/psy1302047s
584. Stringaris, A., & Krieger, F. (2013). Bipolar disorder and disruptive mood dysregulation in children and adolescents: assessment, diagnosis and treatment. Evidence-Based Mental Health. https://doi.org/10.1136/eb-2013-101400
585. Stringer, J. D. (2016). Gender and Sexual Health: Sexual Dysfunction.. PubMed.
586. Stroe, A. Z., Ciorabai, E. M., Pantu, C., Stuparu, A. F., Muja, L., Vranau, D., Axelerad, S. D., & Axelerad, A. D. (2023). Unveiling the Mind: A Comprehensive Review of Psychiatric Disorders in Parkinson’s Disease. Ars medica tomitana. https://doi.org/10.2478/arsm-2023-0007
587. SUMINAR, T. E. L., & Diniari, N. K. S. (2023). GANGGUAN CEMAS PADA LANSIA : SEBUAH LAPORAN KASUS. HEALTHY Jurnal Inovasi Riset Ilmu Kesehatan. https://doi.org/10.51878/healthy.v2i2.2574
588. Summers, C. B. (2007). Cognitive-Behavior Group Therapy in Residential Treatment. https://doi.org/10.4324/9780203941157-16
589. Sung, H. C., & Chang, A. B. (2010). The effectiveness of preferred or familiar music listening on behavioural and psychological symptoms of institutionalised older adults with dementia: a systematic review. JBI Library of Systematic Reviews. https://doi.org/10.11124/jbisrir-2010-726
590. Sung, H. C., & Chang, A. B. (2010). The effectiveness of preferred or familiar music listening on behavioural and psychological symptoms of institutionalised older adults with dementia: a systematic review. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/01938924-201008341-00020
591. Swain, S. K. (2023). Persistent Postural-perceptual Dizziness: A Review. Apollo Medicine. https://doi.org/10.4103/am.am_144_23
592. Syamsir, B. S. (2010). Gangguan Depresif pada Orang Usia Lanjut.
593. Szyguła‐Jurkiewicz, B., Szymik, M., Mrozowska, B., Schmidt, B., & Michalak, A. (2011). Psychologiczne uwarunkowania i konsekwencje ostrego zawału serca. Leki psychotropowe u chorych po ostrym zawale serca. Choroby Serca i Naczyń.
594. Sánchez, J. M. (2014). Responsabilidad penal del drogodependiente. Revista electrónica de ciencia penal y criminología.
595. Sánchez, L. C., Cardona, A., cordoba, S., Silva, A. V., Ruiz, A. C., Ibáñez‐Pinilla, M., Pérez-Olmos, I., & Flórez, J. (2010). Experiencias de estigma en personas con enfermedad mental y su impacto en la autoestima en Colombia. reponame:Repositorio Institucional EdocUR.
596. Sönmez, D., Okumuş, B., & Hocaoğlu, Ç. (2021). The Occurrence of Funeral Mania After Bereavement: A Case Report. Medeniyet Medical Journal. https://doi.org/10.5222/mmj.2021.58998
597. Takayama, T. (1998). Premenstrual syndromes.. PubMed.
598. Tamminga, C. A., Buchanan, R. W., & Gold, J. M. (1998). The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199803003-00004
599. Tan, B. L. W., & Gudi, A. (2021). A rare case: Mania associated with pazopanib. Proceedings of Singapore Healthcare. https://doi.org/10.1177/20101058211023778
600. Tanaka, M., Tajima, S., Mizuno, K., Ishii, A., Konishi, Y., Miike, T., & Watanabe, Y. (2015). Frontier studies on fatigue, autonomic nerve dysfunction, and sleep-rhythm disorder. The Journal of Physiological Sciences. https://doi.org/10.1007/s12576-015-0399-y
601. Tang‐Wai, D. F., Josephs, K. A., & Petersen, R. C. (2005). Alzheimer's disease: overview. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544873.029
602. Taoufiq, P. I. (2024). Cognitive behavioral therapy for a case of addiction with personality disorder (clinical case study). ARID International Journal of Social Sciences and Humanities. https://doi.org/10.36772/arid.aijssh.2024.s.69
603. Tatsuzawa, Y., Ono, Y., Takahashi, T., Yoshino, A., & Nomura, S. (2011). Case of isolated adrenocorticotropic hormone deficiency mimicking major depressive disorder. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.2011.02207.x
604. Taylor, D. J., Lichstein, K. L., & Durrence, H. H. (2003). Insomnia as a Health Risk Factor. Behavioral Sleep Medicine. https://doi.org/10.1207/s15402010bsm0104_5
605. Teasell, R., & Finestone, H. M. (1999). Socioeconomic Factors and Work Disability: Clues to Managing Chronic Pain Disorder. Pain Research and Management. https://doi.org/10.1155/1999/168470
606. Tedyanto, E. H., Widyadharma, I. P. E., Adnyana, M. O., & Wijayanti, I. A. S. (2024). Chronic Pain and Erectile Dysfunction: Mechanism, Treatment, and Future Perspective. Malaysian Journal of Medicine and Health Sciences. https://doi.org/10.47836/mjmhs.20.1.38
607. Telbizova, T., Aleksandrov, I., & Arnaoudova, M. (2020). DYNAMICS OF PSYCHIATRIC SYMPTOMS IN CUSHING’S SYNDROME. Journal of IMAB - Annual Proceeding (Scientific Papers). https://doi.org/10.5272/jimab.2020264.3443
608. Terçariolli, B. I., Rosa, J. M., Vieira, G. P., Cardoso, R., & Lage, P. S. (2024). RESUMO Introdução: Os transtornos mentais são definidos como sendo síndromes caracterizadas por uma perturbação clinicamente expressiva na cognição, na regulação emocional ou no comportamento de um indivíduo, que refletem uma disfunção nos processos psicológicos, biológicos ou de desenvolvimento subjacentes ao funcionamento mental. Estes estão frequentemente associados ao sofrimento ou às incapacidades. Sabe-se que uma das características marcantes de determinados transtornos está relacionada à…. Revista fisio&terapia.. https://doi.org/10.69849/revistaft/fa1020240911111905
609. Tharani, Z., Musaddique, A., & Qutb, S. H. (2023). Burnout and its impact on Nurses and Doctors. Journal of the Pakistan Medical Association. https://doi.org/10.47391/jpma.23-69
610. Thomsen, L. L., & Olesen, J. (2013). Autonomic aspects of migraine: pathophysiology and treatment. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198566342.003.0070
611. Tito, E., Knapp, B., Bucca, A., & Espiridion, E. D. (2019). A Case Report of Schizoaffective Disorder with Pseudoseizures in a 42-year-old Male. Cureus. https://doi.org/10.7759/cureus.4835
612. Todorović, S. (2016). Socijalno medicinske karakteristike i razlike između alkoholičara sa periodičnim i kontinuiranim pijenjem / Social and Medical Characteristics and Differences Between Alcoholics With Periodic and Continuous Drinking. SESTRINSKI ŽURNAL. https://doi.org/10.7251/sez0116005t
613. Tomljanović, M. (2018). Tajne dugovječnosti sadomazohističkih odnosa.
614. Tong, G., Groom, K. N., Ward, L., & Naeem, M. Y. (2021). “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6619579
615. Topinková, E. (2008). Aging, Disability and Frailty. Annals of Nutrition and Metabolism. https://doi.org/10.1159/000115340
616. Torre, A. L., Conca, A., Duffy, D., Giupponi, G., Pompili, M., & Grözinger, M. (2013). Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review Part II: Antipsychotics. Pharmacopsychiatry. https://doi.org/10.1055/s-0033-1347177
617. Trejo, N. L. A., & Castillo-Martínez, J. Á. (2023). Premenstrual dysphoric disorder and its psychological affectation in the workplace. Journal of Basic and Applied Psychology Research. https://doi.org/10.29057/jbapr.v5i9.7750
618. Trojanowska, M. (2017). Społeczny i medyczny wymiar seksualności osób z niepełnosprawnością na przykładzie osób chorych na stwardnienie rozsiane. Acta Universitatis Lodziensis Folia Sociologica. https://doi.org/10.18778/0208-600x.60.08
619. Truyol, C. D. C. G., & Psicología, M. E. (2017). Factores de vulnerabilidad asociados a la génesis del trastorno depresivo persistente (distimia) con ansiedad en un paciente adulto mayor.
620. Tsuji, M., & Nakajima, T. (1991). A Case of Alcoholic Dementia with Hypomagnesemia and Hypocalcemia. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.1991.tb00501.x
621. Tungpunkom, P., Srikhachin, P., Napa, W., & Chaniang, S. (2012). Caregiving Experiences of Families Living with Patients with Schizophrenia: a Systematic Review.. JBI Library of Systematic Reviews. https://doi.org/10.11124/jbisrir-2012-324
622. Turk, J., Graham, P., & Verhulst, F. C. (2007). Introduction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199216697.003.0001
623. Tuğlu, C., & Şahin, Ö. Ö. (2010). Erişkin Dikkat Eksikliği Hiperaktivite Bozukluğu: Nörobiyoloji, Tanı Sorunları ve Klinik Özellikler. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry. https://doi.org/10.18863/pgy.26599
624. Ubaidi, B. A. A. (2017). Integrate of Spiritual Needs into Patient Care. Journal of Family Medicine and Disease Prevention. https://doi.org/10.23937/2469-5793/1510056
625. Ungvári, G. S., & Mullen, P. E. (2000). Reactive psychoses revisited. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1046/j.1440-1614.2000.00752.x
626. Ungvári, G. S., & Mullen, P. E. (2000). Reactive Psychoses Revisited. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1080/j.1440-1614.2000.00752.x
627. Unknown (2008). Bipolare Störungen - Behandlung von manischen Episoden bei der Bipolar-I-Störung. psychoneuro. https://doi.org/10.1055/s-2008-1079282
628. Unknown (2008). Chronic renal failure and sexual dysfunction. CRC Press eBooks. https://doi.org/10.3109/9780203091807-63
629. Uppal, T., Amarasekara, C., & Kaushik, V. (2011). Chronic pelvic pain. Australasian Journal of Ultrasound in Medicine. https://doi.org/10.1002/j.2205-0140.2011.tb00182.x
630. Uppalapati, M., Strohl, K. P., & Sibilia, R. (2021). 854 Sexsomnia in a Divorce Proceeding and its Custody Implications. SLEEP. https://doi.org/10.1093/sleep/zsab072.851
631. Usman, S. B., Indusekhar, R., & O’Brien, S. (2007). Hormonal management of premenstrual syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology. https://doi.org/10.1016/j.bpobgyn.2007.07.001
632. Usón, J. R. V., & Gracia, A. C. I. (2009). Trastorno por déficit de atención/hiperactividad en adultos. Revista de Neurología. https://doi.org/10.33588/rn.48s02.2009017
633. Valente, S. M. (2015). Evaluating and Managing Insomnia: Non-pharmacological Treatments. Journal of Sleep Disorders & Therapy. https://doi.org/10.4172/2167-0277.1000189
634. Vanderschuren, L. J. M. J. (2008). Neurobehavioral Mechanisms of Compulsive Drug Seeking. https://doi.org/10.1093/oso/9780195300550.003.0009
635. Vanselow, W. (1998). A comprehensive approach to premenstrual complaints.. PubMed.
636. Vargas, J. K. R. F. (1999). Artículos de Revisión.
637. Vasiliu, O., & Vasile, D. (2016). Risk factors and quality of life in late-life depressive disorders. Romanian Journal of Military Medicine. https://doi.org/10.55453/rjmm.2016.119.3.5
638. Verny, M. (2000). Approche diagnostique d'un syndrome démentiel chez le sujet âgé. La Revue de gériatrie.
639. Vgontzas, A. N., Fernández‐Mendoza, J., Bixler, E. O., Singareddy, R., Shaffer, M. L., Calhoun, S. L., Liao, D., Basta, M., & Chrousos, G. P. (2011). Persistent Insomnia: the Role of Objective Short Sleep Duration and Mental Health. SLEEP. https://doi.org/10.5665/sleep.1586
640. Vidić, M. (2018). Psihološki aspekti ovisnosti o psihoaktivnim tvarima.
641. Vijay, P., Aziz, S., & Chaudhury, S. (2023). A Rare Case of Very Young-Onset Dementia Presenting as Conversion Disorder. Medical Journal of Dr D Y Patil Vidyapeeth. https://doi.org/10.4103/mjdrdypu.mjdrdypu_174_23
642. Viljoen, M. F. (2015). Sleep tips for insomnia patients. Mental Health Matters.
643. Villamar, S., & Lorena, J. (2019). Factores psicosociales y depresión geriátrica en un paciente.
644. Villarroya, B. G., Voicu, A., Catalán, P. T., & Lopez, P. (2021). La soledad en el anciano, presentación de un caso clínico. Revista Sanitaria de Investigación.
645. Vlăsceanu, G. (2023). From the secrets of longevity... nutraceutics – part XVII. Sleep disorders due to nutritional imbalances. Farmacist ro. https://doi.org/10.26416/farm.214.5.2023.8766
646. Volpe, F. M., & Tavares, A. (2000). Cyproterone for Hypersexuality in a Psychotic Patient with Wilson's Disease. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1080/j.1440-1614.2000.0822l.x
647. Vorchheimer, M. (2018). Keeping tension close to the limit: from latency towards development. Routledge eBooks. https://doi.org/10.4324/9780429473883-11
648. Víu, C. M. D., & Blasco, J. M. (2011). Salud laboral y salud mental: estado de la cuestión. Medicina y Seguridad del Trabajo. https://doi.org/10.4321/s0465-546x2011000500001
649. Wa, D. (1985). Growth at adolescence. Clinical correlates.. PubMed.
650. Wagner, G., & Tejada, I. S. D. (1998). Fortnightly review: Update on male erectile dysfunction. BMJ. https://doi.org/10.1136/bmj.316.7132.678
651. Wahyuni, A. A. S., WIGUNA, I. G. R. P., & Aditya, M. R. (2023). WAHAM SOMATIK : SEBUAH TINJAUAN PUSTAKA. Jurnal Hasil Penelitian dan Pengembangan (JHPP). https://doi.org/10.61116/jhpp.v1i3.156
652. Walker, J., & Littlejohn, G. (2006). Measuring quality of life in rheumatic conditions. Clinical Rheumatology. https://doi.org/10.1007/s10067-006-0450-8
653. Wang, S. (2013). Research development of posttraumatic growth and metal health. Chinese Journal of Injury Repair and Wound Healing.
654. Wang, W. (2011). [Psychological factors involved in erectile dysfunction].. PubMed.
655. Ward, R., & Manchip, S. (2012). ‘Inappropriate’ sexual behaviours in dementia. Reviews in Clinical Gerontology. https://doi.org/10.1017/s0959259812000196
656. Webb, A. M. B., Ford, S. C., & Santiago, P. N. (2018). Adjustment Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190457136.003.0005
657. Weis, J., & Horneber, M. (2014). Cancer-Related Fatigue.
658. Weiss, P., Urbánek, V., & Kozmiková, T. (1997). [Psychologic causes of erectile dysfunction].. PubMed.
659. Westby, A., & Coburn-Pierce, M. (2018). Autism spectrum disorder in primary care. The Nurse Practitioner. https://doi.org/10.1097/01.npr.0000530326.85465.8b
660. Wettstein, R. M., & Kelly, J. (2016). A PHARMACOLOGICAL APPROACH TO SEXUALLY DEVIANT BEHAVIOR IN THE COMMUNITY.
661. White-Campbell, M. (2018). The older adult. CRC Press eBooks. https://doi.org/10.4324/9781315383491-11
662. Wierman, M. E., & Cassel, C. K. (1998). Erectile Dysfunction: A Multifaceted Disorder. Hospital Practice. https://doi.org/10.3810/hp.1998.10.111
663. Williams, W. (1985). Psychogenic Erectile Impotence — A Useful Or a Misleading Concept?. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.3109/00048678509158817
664. Witten, T., Noor, N., & Moss, C. (2023). Chronic Pelvic Pain. Cambridge University Press eBooks. https://doi.org/10.1017/9781108979849.037
665. Wout‐Frank, M. V. ‘. (2006). The nature of emotional abnormalities in schizophrenia: Evidence from patients and high-risk individuals.
666. Wróbel, M. R., & Mosiołek, A. (2018). Dysfunkcje seksualne w przebiegu zaburzeń depresyjnych.
667. Wuergezhen, D. (2019). The influences of genes and early life stress on the HPA axis regulation.
668. Wulff, C., Lindfors, P., & Sverke, M. (2010). Are general mental ability and psychosocial work characteristics related to midlife health in working women and men. USC Research Bank (University of the Sunshine Coast).
669. Wulff, C., Lindfors, P., & Sverke, M. (2011). Do general mental ability and psychosocial work characteristics predict different aspects of health in middle-aged working women and men?.
670. Xiao, J., Chan, C. W., & Chow, K. M. (2019). LIVING WITH DIGNITY AMONG CHINESE CANCER PATIENTS UNDERGOING CHEMOTHERAPY: A QUALITATIVE STUDY. https://doi.org/10.26226/morressier.5cdbe0ab618793e647b12cfb
671. Yadav, P., Chauhan, V. S., Goyal, S., & Khan, S. (2016). Two cases of male genital self-mutilation. Industrial Psychiatry Journal. https://doi.org/10.4103/0972-6748.207854
672. Yakovenko, S., & Rostomova, L. (2016). CONSIDERATION FOR CHILDREN IN CASE OF PARENTS’ DIVORCE. Science and Education. https://doi.org/10.24195/2414-4665-2016-9-36
673. Yarlagadda, A. R., Brown, A. B., & Clayton, A. H. (2007). Onset of Obstructive Sleep Apnea After Initiation of Psychotropic Agents. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611h
674. Yasui‐Furukori, N., Yoshida, R., & Shimoda, K. (2022). Sex Differences in and Pharmacotherapy of Schizophrenia. IntechOpen eBooks. https://doi.org/10.5772/intechopen.106003
675. Yetkın, S., & Çor, S. A. (2023). Psychological Inflexibility in Depression with Psychotic Features: A Case Report. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.2180
676. Yoshida, M. (2017). Lower urinary tract dysfunction and comprehensive geriatric assessment in the elderly.. PubMed.
677. Yönt, Y. D. D. H., & Korhan, A. G. D. E. A. (2010). İnmeli Hastalarda İhmal Edilen Bir Sorun: Patolojik Gülme ve Ağlama. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi.
678. Zajecka, J. (2001). Strategies for the treatment of antidepressant-related sexual dysfunction.. PubMed.
679. Zitzmann, M., & Rohayem, J. (2020). Gonadal dysfunction and beyond: Clinical challenges in children, adolescents, and adults with 47,<scp>XXY</scp>Klinefelter syndrome. American Journal of Medical Genetics Part C Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.31786
680. Zschucke, E., Gaudlitz, K., & Ströhle, A. (2013). Exercise and Physical Activity in Mental Disorders: Clinical and Experimental Evidence. Journal of Preventive Medicine and Public Health. https://doi.org/10.3961/jpmph.2013.46.s.s12
681. Zucconi, M., & Manconi, M. (2008). Sleep and Quality of Life in Restless Legs Syndrome. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-343-5_11
682. Zulkifli, N., Khuzaini, A. M., Aziz, A. A., & Awang, H. (2023). Trauma-related hallucination in an 8-year-old child with dissociative symptoms. Deleted Journal. https://doi.org/10.4103/mjp.mjp_10_23
683. Zutshi, A., Math, S. B., & Reddy, Y. C. J. (2007). Escitalopram in Obsessive-Compulsive Disorder. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611c
684. Zúñiga, R. L. (2017). Delirium y la presencia de respuesta inflamatoria sistémica, descontrol glucémico e hipoxia en pacientes mayores de 65 años en el servicio de urgencias médicas del Hospital General de Pachuca..
685. Çelik, A. S., & Pasinlioğlu, T. (2013). KLİMAKTERİK DÖNEMDE YAŞANAN SEMPTOMLAR VE HEMŞİRENİN ROLÜ.
686. Østensen, M. (2018). SP0046 What we need to consider in physician-patient communication on sexual problems in different rheumatic conditions. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2018-eular.7832
687. Østergaard, S. D., Seidler, Z. E., & Rice, S. (2023). The <scp>ICD</scp>‐11 opens the door for overdue improved identification of depression in men. World Psychiatry. https://doi.org/10.1002/wps.21124
688. Świaczny, S. (2011). Nerwica natręctw a kanoniczny konsens małżeński. Annales Canonici. https://doi.org/10.15633/ac.0714
689. Żuk, B., & Maślińska, M. (2017). The importance of physiotherapy in the sexuality of patients with rheumatic diseases. Reumatologia/Rheumatology. https://doi.org/10.5114/reum.2017.71640